Luminescent compounds

By synthesizing and adjusting the structure of polycyclic aromatic hydrocarbon derivatives, the problems of insufficient Stokes shift and brightness of benzo[a]phenanthrene derivatives in the prior art have been solved, achieving large Stokes shift and high brightness luminescence performance, which is suitable for electronic devices such as OLEDs, LEDs and solar cells.

CN118955418APending Publication Date: 2024-11-15CROMARTWEST GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410983225.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2018-03-21
Filing Date
2019-03-21
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing technologies struggle to produce benzo[a]phenanthrene derivatives with large Stokes shift, high brightness, high molar extinction coefficient, and high quantum yield, and it is also difficult to tune their absorption and emission energies to achieve luminescent compounds with specific visible colors.

Method used

By synthesizing polycyclic aromatic hydrocarbon derivatives with specific structures, and through intramolecular rearrangement or intermolecular coupling reactions, benzo[a]phenanthrene derivatives with different substituents are prepared, and their luminescent properties are adjusted.

Benefits of technology

It achieves light-emitting performance with large Stokes frequency shift, high brightness and high quantum yield, and can emit light across the entire visible spectrum, making it suitable for electronic devices such as OLEDs, LEDs and solar cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118955418A_ABST
    Figure CN118955418A_ABST
Patent Text Reader

Abstract

A polycyclic aromatic hydrocarbon derivative represented by the following general formula: (I) wherein R independently represents an aromatic group and / or an aliphatic group; q is one of a cyclic aliphatic hydrocarbon, a cyclic aromatic hydrocarbon, a polycyclic hydrocarbon, a polycyclic aromatic hydrocarbon and / or a fused polycyclic aromatic hydrocarbon; wherein the substituents independently include one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group, and / or an aryl group; p is an integer from 1 to 2; q is an integer from 1 to 4; y1 and Y2 independently represent one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group, and / or an aryl group; and x is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more. # imgabs0 #
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of the invention patent application with application number 201980033490.6, application date March 21, 2019, and invention name “Luminescent Compounds”. Technical Field

[0002] The present invention relates generally to organic light-emitting compounds. More particularly, although not exclusively, the present invention relates to novel light-emitting polycyclic aromatic hydrocarbon (eg, triphenylene) derivatives, methods of synthesizing them, their uses, and devices containing them. Background Art

[0003] Luminescent compounds are widely used in industrial and research applications such as dyes, probes, sensors, and electronic devices. These molecules emit light upon excitation by external energy, such as from a source such as light and / or electric current.

[0004] In photoluminescence, when exposed to light, a luminescent compound will absorb light of a specific wavelength and re-emit light of a different wavelength. The type of light emission observed depends on the molecular structure of the compound.

[0005] The difference between the maximum excitation wavelength and the emission wavelength of a luminescent compound is called the Stokes shift. For use as dyes, probes and / or sensors in industrial applications, it is advantageous for luminescent compounds to have a large Stokes shift, which is generally defined as greater than 8000 cm -1 , i.e. a relatively large difference between the excitation wavelength and the emission wavelength. This is advantageous because it minimizes the reabsorption of light emitted from the molecule.

[0006] A disadvantage of many fluorescent dyes with large Stokes shifts is their relatively low brightness, which is defined as the product of the molar extinction coefficient and the fluorescence quantum yield. In addition, dyes with large Stokes shifts often suffer from poor photostability (Methods Appl. Fluoresc. 3 (2015) 042004).

[0007] Luminescent organometallic complexes often have large Stokes shifts. However, these contain rare, expensive metal centers such as osmium, ruthenium, iridium, rhenium, etc., and these complexes are often difficult to synthesize and are often toxic. Luminescent organic molecules are generally easier to synthesize, but usually exhibit relatively small Stokes shifts.

[0008] In contrast, in electroluminescence, a luminescent compound will emit light in response to an electric current. One of the main applications of this phenomenon is in electronic devices containing OLEDs (organic light emitting diodes). OLED materials are layers of luminescent organic compounds that are located between two electrodes, one of which is usually transparent. This technology is used for digital displays in electronic devices such as television screens, computer monitors, mobile phones, electroluminescent lighting panels, etc.

[0009] It is advantageous for luminescent compounds for electroluminescent applications to display high brightness. Brightness is defined as the product of the molar extinction coefficient (E) and the fluorescence quantum yield (Φ) divided by 1000. Therefore, it is advantageous for luminescent compounds to exhibit a high molar extinction coefficient (E) (defined by the Beer-Lambert law, where A is the absorbance, c is the molar concentration of the luminescent compound, and l is the path length) and a high quantum yield (Φ) as a measure of efficiency.

[0010] As is well known, polycyclic aromatic hydrocarbons exhibit luminescent properties. One class of such compounds is triphenylene and its derivatives. For example, triphenylene can be functionalized with alkoxy chains attached to the periphery of the molecule. In addition, these derivatives exhibit discotic liquid crystal (DLC) behavior (J.Nabar and A.Chodkowska, Luminescence, 1975, 11, 215). The discotic liquid crystal behavior is characterized in that the discoid molecules form stacks or columns in the mesophase, which allows charge transfer by π stacking, making the material semiconductive in the stacking direction. This DLC behavior, combined with luminescent properties, is particularly suitable for use in technologies such as electronic devices using OLED (organic light emitting diodes), LED (light emitting diodes), and in solar cells.

[0011] It is also known that light-emitting compounds exhibit photoconductivity, wherein the compound exhibits increased electrical conductivity in the presence of light by converting light energy into electrical current. It is known to use compounds having good photoconductivity in devices such as solar cells.

[0012] Although many luminescent triphenylene derivatives have been synthesized and characterized (e.g., Levell et al., J. Phys. Chem. A., 2010, 114, 13291), it remains a challenge to provide triphenylene derivatives having the above-mentioned advantageous properties, i.e., large Stokes shift, high brightness, high molar extinction coefficient, and high quantum yield. In addition, it remains a challenge to provide a range of luminescent compounds that emit wavelengths across the entire visible spectrum. In particular, providing blue emitters is a particular challenge (Chem Soc Rev. 2013 Jun 21; 42(12): 4963-76).

[0013] Furthermore, it remains a challenge to provide luminescent triphenylene derivatives, in which the absorption and emission energies can be predicted and tuned through design and synthesis to produce specific and desired visible colors (Methods Appl. Fluoresc. 3 (2015) 042004). Summary of the invention

[0014] Therefore, the first aspect of the present invention provides a polycyclic aromatic hydrocarbon derivative represented by the following general formula:

[0015]

[0016] wherein R independently represents an aromatic group and / or an aliphatic group;

[0017] Q is one of a cyclic aliphatic hydrocarbon, a cyclic aromatic hydrocarbon, a polycyclic hydrocarbon, a polycyclic aromatic hydrocarbon and / or a condensed polycyclic aromatic hydrocarbon; wherein the substituents independently include one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0018] p is an integer from 1 to 2;

[0019] q is an integer from 1 to 4;

[0020] Y 1 and Y 2 independently represent one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0021] and x is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more.

[0022] In an embodiment, Q may represent CH. In an embodiment, Q is a polycyclic aromatic hydrocarbon, for example, Q may be one of naphthalene, anthracene, phenanthrene, tetracene, chrysene, triphenylene, pyrene, pentacene, benzo[a]pyrene, corannulene, benzo[ghi]perylene, coronene, ovalene, fullerene and / or benzo[c]fluorene. Q may be any isomer of the polycyclic aromatic hydrocarbon, for example, 1-naphthalene, 2-naphthalene, 2-anthracene, 9-anthracene. The polycyclic aromatic hydrocarbon group may be substituted by other moieties such as aryl, alkyl, heteroatom and / or other electron withdrawing or electron donating groups.

[0023] Q is bonded to other six-membered rings, such as aromatic six-membered rings and / or substituted aromatic six-membered rings. The number of six-membered rings bonded to Q is represented by the integer x, where x is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more.

[0024] In one embodiment, Q is an aromatic six-membered ring, and x is an integer of 2 or greater, for example, 1, 2, 3, 4, 5, or more.

[0025] In an embodiment, the polycyclic aromatic hydrocarbon (eg, triphenylene) derivative may be represented by the following general formula:

[0026]

[0027] wherein D is a hydrogen atom, a deuterium atom, a silicon atom or a carbon atom;

[0028] p is an integer from 1 to 2;

[0029] q is an integer from 1 to 2;

[0030] Y 1 and Y 2 independently represent one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0031] and x is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more.

[0032] For example, D can be a linear or branched alkyl chain, an aryl group, or a combination thereof.

[0033] The polycyclic aromatic hydrocarbon (e.g., triphenylene) derivative can be represented by the following general formula:

[0034]

[0035] wherein D is a hydrogen atom, a deuterium atom, a silicon atom or a carbon atom;

[0036] p is an integer from 1 to 2;

[0037] q is the integer 1;

[0038] Y 1 and Y 2 independently represent one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0039] and x is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or more.

[0040] For example, D can be a linear or branched alkyl chain, an aryl group, or a combination thereof.

[0041] Another aspect of the present invention provides a polycyclic aromatic hydrocarbon derivative represented by the following general formula:

[0042]

[0043] wherein R independently represents an aromatic group and / or an aliphatic group;

[0044] p is an integer from 1 to 2;

[0045] q and s are independently integers from 1 to 4;

[0046] Y 1 , Y 2 and Y 3 independently represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group (e.g., a phenolic group).

[0047] In an embodiment, the polycyclic aromatic hydrocarbon derivative may be a triphenylene derivative. In an alternative embodiment, the polycyclic aromatic hydrocarbon derivative may include a fused polycyclic aromatic hydrocarbon containing six 6-membered rings.

[0048] Y 1 , Y 2 and Y 3 It may contain carboxylic acid groups, diol groups, alkoxy groups, thioalkoxy groups, amino groups, acetate groups, amide groups, thioamide groups, thioester groups, azo groups and / or silyl groups. Additionally or alternatively, Y 1 , Y 2 and Y 3 The alkyl group may be linear, or may contain branches, and / or may be further functionalized. Additionally or alternatively, Y 1 , Y 2 and Y 3 Aryl groups may be included. The aryl groups may be unsubstituted or may be further functionalized.

[0049] The integer p may be 1 to 2. The integer q may be 1, 2, 3, or 4. The integer s may be 1, 2, 3, or 4.

[0050] Another aspect of the present invention provides a polycyclic aromatic hydrocarbon derivative represented by the following general formula:

[0051]

[0052] wherein R independently represents an aromatic group and / or an aliphatic group;

[0053] q is independently an integer from 1 to 3;

[0054] s is independently an integer from 1 to 4;

[0055] t is independently an integer from 1 to 4;

[0056] Y 2 , Y 3 , Y 4 and J independently represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group (e.g., a phenol group).

[0057] In an embodiment, the polycyclic aromatic hydrocarbon derivative is a triphenylene derivative represented by the following general formula:

[0058]

[0059] wherein R independently represents an aromatic group and / or an aliphatic group;

[0060] A independently represents a hydrogen atom, an aryl group, an alkyl group containing 1 to 20 carbons (e.g., 1 to 15 carbons, or 1 to 10 carbons, or 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 carbon), or an alkyl ether;

[0061] J independently represents a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group (e.g., a phenol group).

[0062] In an embodiment, A may be C5H 11 and / or C4H9. In an embodiment, A represents a polyethylene glycol (PEG) group (eg C2H4OC2H4OC2H4OCH3).

[0063] In an embodiment, the triphenylene derivative may not be one in which A is C5H 11 , J is H and R is C4H9.

[0064] In an embodiment, the polycyclic aromatic hydrocarbon is represented by the following general formula:

[0065]

[0066] Where R 1 and R 2independently represent an aromatic group and / or an aliphatic group;

[0067] p and q are independently integers from 1 to 2;

[0068] s is an integer from 1 to 4;

[0069] Y 1 , Y 2 and Y 3 independently represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (eg, an alkylated oxygen atom), a nitrogen atom (eg, an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group.

[0070] In an embodiment, the polycyclic aromatic hydrocarbon is a triphenylene derivative represented by the following general formula:

[0071]

[0072] Where R 1 and R 2 independently represent an aromatic group and / or an aliphatic group;

[0073] A independently represents a hydrogen atom, an aryl group, an alkyl group containing 1 to 20 carbons (e.g., 1 to 15 carbons, or 1 to 10 carbons, or 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 carbon), or an alkyl ether;

[0074] J independently represents a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (eg, an alkylated oxygen atom), a nitrogen atom (eg, an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group.

[0075] In an embodiment, A may be C5H 11 and / or C4H9. In an embodiment, A represents a polyethylene glycol (PEG) group (eg C2H4OC2H4OC2H4OCH3).

[0076] In an embodiment, the polycyclic aromatic hydrocarbon is represented by the following general formula:

[0077]

[0078] Where R 1 , R 2 and R 3 independently represent an aromatic group and / or an aliphatic group;

[0079] p, q and s are each independently an integer from 1 to 2;

[0080] Y 1 , Y 2 and Y 3independently represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (eg, an alkylated oxygen atom), a nitrogen atom (eg, an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group.

[0081] In an embodiment, the polycyclic aromatic hydrocarbon is a triphenylene derivative represented by the following general formula:

[0082]

[0083] Where R 1 , R 2 and R 3 independently represent an aromatic group and / or an aliphatic group;

[0084] A independently represents a hydrogen atom, an aryl group, an alkyl group containing 1 to 20 carbons (e.g., 1 to 15 carbons, or 1 to 10 carbons, or 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 carbon), or an alkyl ether;

[0085] J independently represents a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (eg, an alkylated oxygen atom), a nitrogen atom (eg, an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group.

[0086] In an embodiment, A comprises other functional groups, for example, A may further comprise a fluorine atom, a chlorine atom, a cyano group, a nitro group, a glycol group, an alkoxy group, a thioalkoxy group, a polyethylene glycol group, an amino group, an acetate group, a carboxylic acid group, an amide group, a thioamide group, a thioester group, an azo group and / or a silyl group.

[0087] In an embodiment, J comprises or represents an aryl group, such as a phenolic group. Additionally or alternatively, J comprises a halogen atom, such as fluorine, chlorine, bromine or iodine.

[0088] In an embodiment, R, R 1 , R 2 or R 3 can be an alkyl group, such as a linear or branched alkyl chain. In an embodiment, R, R 1 , R 2 , R 3 At least one of them may be methyl, ethyl, propyl, or butyl.

[0089] Among them, R, R 1 , R 2 or R 3 In the embodiment of being an aromatic group, the aromatic group may be one or a combination of an aromatic hydrocarbon group and / or an aromatic heterocyclic group.

[0090] Among them, R, R 1 , R2 or R 3 In the embodiment of aromatic hydrocarbon group, the aromatic hydrocarbon group may include one or a combination of phenyl ring and / or substituted phenyl ring. On phenyl ring, there may be one, two, three, four or five other substituents. The substituent is directly bonded to the phenyl ring, and may be fluorine, chlorine, bromine, iodine, hydroxyl, amine, nitro, alkoxy, carboxylic acid, amide, cyano, trifluoromethyl, ester, olefin, alkyne, azide, azo, isocyanate, ketone, aldehyde, the alkyl consisting of hydrocarbon chain, or hydrocarbon ring, the alkyl consisting of other heteroatoms such as fluorine, chlorine, bromine, iodine, oxygen, nitrogen and / or sulphur, or a combination thereof. The alkyl group may include, for example, hydroxyl, amine, nitro, ether group, carboxylic acid, amide, cyano, trifluoromethyl, ester, olefin, alkyne, azide, azo, isocyanate, ketone, aldehyde. The substituent may be another aromatic group, for example, and R may include a phenyl substituted by another phenyl ring. In embodiments, the R group may be a benzene ring substituted with a second benzene ring, which in turn is substituted with a third benzene ring.

[0091] Among them, R, R 1 , R 2 or R 3 In the embodiment where the aromatic group is an aromatic group, the aromatic group can be a polycyclic aromatic hydrocarbon, such as naphthalene, anthracene, phenanthrene, tetracene, chrysene, triphenylene, pyrene, pentacene, benzo[a]pyrene, coronene, benzo[ghi]perylene, coronene, ovalene, fullerene and / or benzo[c]fluorene. The R group can be bonded to the triphenylene derivative through any isomer of the polycyclic aromatic hydrocarbon (e.g., 1-naphthalene, 2-naphthalene, 2-anthracene, 9-anthracene). The polycyclic aromatic hydrocarbon group can be substituted by other structural parts such as aryl, alkyl, heteroatoms and / or other electron withdrawing or electron donating groups.

[0092] Among them, R, R 1 , R 2 or R 3 In the embodiment of being an aromatic heterocyclic group, the heterocyclic group can be a three-membered ring, a four-membered ring, a five-membered ring, a six-membered ring, a seven-membered ring, an eight-membered ring, a nine-membered ring, a ten-membered ring or a condensed ring. In the embodiment, the heterocyclic group can be furan, benzofuran, isobenzofuran, pyrrole, indole, isoindole, thiophene, benzothiophene, benzo[c]thiophene, imidazole, benzimidazole, purine, pyrazole, indazole, oxazole, benzoxazole, isoxazole, benzisoxazole, thiazole, benzothiazole, pyridine, quinoline, isoquinoline, pyrazine, quinoxaline, acridine, pyrimidine, quinazoline, pyridazine, cinnoline, phthalazine, 1,2,3-triazine, 1,2,4-triazine, 1,3,5-triazine, pyridine or thiophene.

[0093] Among them, R, R 1 , R 2 or R 3In the embodiment of aliphatic group, the aliphatic group can be one or a combination of normal alkyl chain, branched alkyl chain, alkyl chain containing unsaturated part, alkyl chain containing heteroatoms such as fluorine, chlorine, bromine, iodine, oxygen, sulfur, nitrogen. The alkyl chain can contain unsaturated part, including olefin or aromatic part. The alkyl chain can contain functional group for further derivatization of polycyclic aromatic hydrocarbon (such as triphenylene) derivative. For example, the functional group can be one or more of azide, carbonyl, alcohol, halogen or olefin.

[0094] In an embodiment, wherein R, R 1 , R 2 or R 3 In embodiments comprising a crown ether.

[0095] The polycyclic aromatic hydrocarbon (eg, triphenylene) derivative can be used as, for example, a luminescent dye for use in a device.

[0096] Another aspect of the present invention provides a device comprising the polycyclic aromatic hydrocarbon derivative, such as a triphenylene derivative. The device may be an electronic device, such as an organic electroluminescent device, a thin film transistor and / or an OPV (organic photovoltaic) device. The electronic device may include a digital display, such as a liquid crystal display, comprising the polycyclic aromatic hydrocarbon derivative, such as a triphenylene derivative, of the present invention. The digital display may be in, for example, a television screen, a computer monitor, a mobile phone screen, a game console. The organic electroluminescent device may include a pair of electrodes and one or more layers interposed therebetween, wherein the one or more layers include one or more polycyclic aromatic hydrocarbon derivatives, such as a triphenylene derivative.

[0097] The device can be used to detect substances, such as ions, such as metal ions. For example, the polycyclic aromatic hydrocarbon derivatives, such as triphenylene derivatives, can include a structural part that can bind to substances such as ions. The structural part can be labeled or integrated into (i.e., covalently bonded to) the polycyclic aromatic hydrocarbon derivatives, such as triphenylene derivatives. The bonding of substances to polycyclic aromatic hydrocarbon derivatives such as triphenylene derivatives can cause a luminescent response. The luminescent response can be recorded to quantitatively or qualitatively measure the presence of substances, such as the presence in a solution. The structural part can be one or more of a crown ether, a multidentate ligand, a bidentate ligand, or a monodentate ligand. The structural part can be the R group of the polycyclic aromatic hydrocarbon (e.g., triphenylene) derivative. The polycyclic aromatic hydrocarbon (e.g., triphenylene) derivative, for example, includes a structural part that can bind to substances such as metal ions. The triphenylene derivative can be spin-coated on a dipstick. The dipstick can include a UVLED (light emitting diode). When combined with the polycyclic aromatic hydrocarbon derivatives such as triphenylene derivatives, in the presence of specific substances such as ions and metal ions, an LED can be illuminated. The LED lighting can be specific to a specific substance bound to the polycyclic aromatic hydrocarbon derivative, such as a phenylene derivative, that is, when bound to a specific substance (substance A), the LED emits light of a specific wavelength (wavelength A), and when bound to a specific substance (substance B), the LED emits light of a different wavelength (wavelength B).

[0098] The device can be used for bioluminescence microscopy. The device can include polycyclic aromatic hydrocarbon derivatives such as triphenylene derivatives as luminescent dyes, which can be used to mark or annotate biological or non-biological samples, which can include DNA or protein or antigen or biomarker.

[0099] The device may include a polymer or prepolymer and / or resin composition for printing, for example, for 3D printing of plastic products containing polycyclic aromatic hydrocarbon derivatives such as triphenylene derivatives. The polycyclic aromatic hydrocarbon (eg triphenylene) derivatives may be used as dopants in the device.

[0100] The polycyclic aromatic hydrocarbon derivatives of the device, such as triphenylene derivatives, can emit light in the visible spectrum (i.e., 380 nm-750 nm). The polycyclic aromatic hydrocarbon derivatives of the device, such as triphenylene derivatives, can exhibit a wavelength of 8000 cm -1 Up to 25,000cm -1 , e.g. 15,000cm -1 Up to 25,000cm -1 The polycyclic aromatic hydrocarbon derivatives of the device, such as triphenylene derivatives, can exhibit a Stokes shift of 5.0×10 -13 S cm -1 to 1.5×10-11 S cm -1 , for example 6×10 -12 S cm -1 to 1.5×10 -11 S cm -1 The polycyclic aromatic hydrocarbon derivatives of the device, such as triphenylene derivatives, can exhibit a conductivity value of 1.5×10 -10 S cm -1 Up to 1×10 -3 Scm -1 , for example 1×10 -8 S cm-1 to 1×10 - 3 Photoconductivity of cm-1.

[0101] Another aspect of the present invention provides a compound for preparing a triphenylene derivative, the compound comprising the following structure:

[0102]

[0103] wherein A independently represents a hydrogen atom, an aryl group, an alkyl group containing 1 to 20 carbons (e.g., 1 to 15 carbons, or 1 to 10 carbons, or 10, 9, 8, 7, 6, 5, 4, 3, 2, or 1 carbon), or an alkyl ether.

[0104] Preferably, in this embodiment, A represents an alkyl chain, for example comprising 1 to 10 carbon atoms, for example 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10 carbon atoms, for example A is C5H 11 .

[0105] Another aspect of the present invention provides a method for synthesizing a polycyclic aromatic hydrocarbon derivative (P1), which comprises the following general formula:

[0106]

[0107] Wherein R represents an aliphatic group;

[0108] A' represents an alkyl chain containing 3 to 20 carbons;

[0109] p is an integer from 1 to 2;

[0110] q and s are independently integers from 1 to 4;

[0111] Y 1 , Y 2 and Y 3 independently represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group (e.g., a phenolic group).

[0112] In this embodiment, (SM1) represents a polycyclic aromatic hydrocarbon core and (P1) represents a triphenylene derivative. In this embodiment, A' represents an alkyl chain comprising 3 to 20 carbon atoms, such as 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 or 20 carbon atoms. In this embodiment, R represents an alkyl chain having one less carbon atom than A'. For example, preferably, A' comprises a linear alkyl chain comprising five carbons, i.e., C5H 11 , R comprises a linear alkyl chain comprising four carbons, ie, C4H9. The method may comprise intramolecular rearrangement of the polycyclic aromatic hydrocarbon (eg, triphenylene) core (SM1) to produce a polycyclic aromatic hydrocarbon (eg, triphenylene) derivative (P1).

[0113] The method may comprise using a solvent, such as an inert solvent.The method may comprise heating the polycyclic aromatic core (SM1) under pressure to produce a polycyclic aromatic hydrocarbon derivative (P1).

[0114] In embodiments, the method may include a catalyst, such as a transition metal catalyst. The transition metal catalyst may be a rhodium catalyst, such as [[CH3(CH2)6CO2]2Rh]2. The method may include heating to reflux using toluene as a solvent in the presence of a transition metal catalyst, such as a rhodium catalyst, such as [[CH3(CH2)6CO2]2Rh]2.

[0115] Another aspect of the present invention provides a method for synthesizing a polycyclic aromatic hydrocarbon derivative (P2), the method comprising the following general formula:

[0116]

[0117] wherein (SM2) represents a polycyclic aromatic hydrocarbon core, and (P2) represents a polycyclic aromatic hydrocarbon derivative;

[0118] Q is one of a substituted or unsubstituted cyclic aliphatic hydrocarbon, a substituted or unsubstituted cyclic aromatic hydrocarbon, a substituted or unsubstituted polycyclic hydrocarbon, a substituted or unsubstituted polycyclic aromatic hydrocarbon and / or a substituted or unsubstituted condensed polycyclic aromatic hydrocarbon; wherein the substituent comprises one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0119] p is an integer from 1 to 2;

[0120] q is an integer from 1 to 4;

[0121] Y 1 and Y 2independently represent one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0122] and x is an integer of 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or greater;

[0123] G is a carbon atom;

[0124] N is a nitrogen atom;

[0125] B is one or more hydrogen atoms; and

[0126] wherein (E) represents the reagent;

[0127] R independently represents an aromatic group and / or an aliphatic group;

[0128] Z is an oxygen atom, a derivatized oxygen atom, a chlorine atom or a bromine atom, or any good leaving group.

[0129] In an embodiment, the nitrogen atom may be an amine (NH2) wherein B contains two hydrogen atoms.

[0130] In an embodiment, the method for synthesizing a polycyclic aromatic hydrocarbon derivative (P3) comprises the following general formula:

[0131]

[0132] wherein (SM3) represents a polycyclic aromatic hydrocarbon core, and (P3) represents a polycyclic aromatic hydrocarbon derivative;

[0133] p is an integer from 1 to 2;

[0134] q and s are integers from 1 to 4;

[0135] Y 1 , Y 2 and Y 3 independently represent one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0136] G is a carbon atom;

[0137] N is a nitrogen atom;

[0138] B is one or more hydrogen atoms;

[0139] (E) represents the reagent;

[0140] R independently represents an aromatic group and / or an aliphatic group;

[0141] Z is one of an oxygen atom, a derivatized oxygen atom, a chlorine atom or a bromine atom, or any good leaving group;

[0142] And wherein the polycyclic aromatic hydrocarbon core (SM3) and the reagent (E) undergo an intermolecular coupling reaction to produce the polycyclic aromatic hydrocarbon derivative (P3).

[0143] In an embodiment, (E) represents the reagent, wherein R is an aromatic group and / or an aliphatic group, and the group Z can be an oxygen atom, or a derived oxygen atom such as one of an OH group, a chlorine atom or a bromine atom, or any good leaving group. The reagent (E) can be an acyl chloride or a carboxylic acid. The method can include reacting the polycyclic aromatic hydrocarbon core (SM3) and the reagent (E) to produce the polycyclic aromatic hydrocarbon derivative (P3).

[0144] In an embodiment, the method for synthesizing a polycyclic aromatic hydrocarbon derivative (P4) comprises the following general formula:

[0145]

[0146] Wherein (SM4) represents a triphenylene core, and (P4) represents a triphenylene derivative;

[0147] A independently represents a hydrogen atom, an aryl group, an alkyl group containing 1 to 20 carbons (e.g., 1 to 15 carbons, or 1 to 10 carbons, or 10, 9, 8, 7, 6, 5, 4, 3, 2 or 1 carbon);

[0148] J independently represents a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (eg, an alkylated oxygen atom), a nitrogen atom (eg, an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group.

[0149] G is a carbon atom;

[0150] (E) represents the reagent;

[0151] R independently represents an aromatic group and / or an aliphatic group;

[0152] Z is one of an oxygen atom, a derivatized oxygen atom, a chlorine atom or a bromine atom, or any good leaving group;

[0153] And wherein the triphenylene core (SM4) and the reagent (E) undergo an intermolecular coupling reaction to produce a triphenylene derivative (P4).

[0154] In an embodiment, the method for synthesizing a triphenylene derivative (100) comprises the following general formula:

[0155]

[0156] wherein R independently represents an aromatic group and / or an aliphatic group.

[0157] Another aspect of the present invention provides a method for synthesizing a polycyclic aromatic hydrocarbon derivative (P6), which comprises the following general formula:

[0158]

[0159] wherein (SM6) represents a polycyclic aromatic hydrocarbon core, and (P6) represents a polycyclic aromatic hydrocarbon derivative;

[0160] p is an integer from 1 to 2;

[0161] q is an integer from 1 to 2;

[0162] s is an integer from 1 to 4;

[0163] Y 1 , Y 2 and Y 3 independently represent one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0164] G independently represents a substituted carbon atom;

[0165] N is a nitrogen atom;

[0166] B is one or more hydrogen atoms;

[0167] (E) represents the reagent;

[0168] R independently represents an aromatic group and / or an aliphatic group;

[0169] Z is one of an oxygen atom, a derivatized oxygen atom, a chlorine atom or a bromine atom, or any good leaving group;

[0170] And wherein the polycyclic aromatic hydrocarbon core (SM6) and the reagent (E) undergo an intermolecular coupling reaction to produce the polycyclic aromatic hydrocarbon derivative (P6).

[0171] The method for synthesizing the polycyclic aromatic hydrocarbon derivative (P7) may include the following general formula:

[0172]

[0173] Wherein (SM7) represents a triphenylene core, and (P7) represents a triphenylene derivative;

[0174] A independently represents a hydrogen atom, an aryl group, an alkyl group containing 1 to 20 carbons (e.g., 1 to 15 carbons, or 1 to 10 carbons, or 10, 9, 8, 7, 6, 5, 4, 3, 2 or 1 carbon);

[0175] J independently represents a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group (e.g., a phenol group).

[0176] G independently represents a substituted carbon atom;

[0177] (E) represents the reagent;

[0178] R independently represents an aromatic group and / or an aliphatic group;

[0179] Z is one of an oxygen atom, a derived oxygen atom, a chlorine atom or a bromine atom;

[0180] And wherein the triphenylene core (SM7) and the reagent (E) undergo an intermolecular coupling reaction to produce a triphenylene derivative (P7).

[0181] The method may include synthesizing a triphenylene derivative, wherein the triphenylene core starting material comprises the formula:

[0182]

[0183] Another aspect of the present invention provides a method for synthesizing a polycyclic aromatic hydrocarbon derivative (P8), which comprises the following general formula:

[0184]

[0185] wherein (SM8) represents a polycyclic aromatic hydrocarbon core, and (P8) represents a polycyclic aromatic hydrocarbon derivative;

[0186] p, q and s are independently integers from 1 to 2;

[0187] Y 1 , Y 2 and Y 3 independently represent one or more of a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group;

[0188] G independently represents a substituted carbon atom;

[0189] N is a nitrogen atom;

[0190] B is one or more hydrogen atoms;

[0191] (E) represents the reagent;

[0192] R independently represents an aromatic group and / or an aliphatic group;

[0193] Z is one of an oxygen atom, a derivatized oxygen atom, a chlorine atom or a bromine atom, or any good leaving group;

[0194] And wherein the polycyclic aromatic hydrocarbon core (SM8) and the reagent (E) undergo an intermolecular coupling reaction to produce the polycyclic aromatic hydrocarbon derivative (P8).

[0195] The method may include synthesizing a triphenylene derivative (P9), including the reaction formula:

[0196]

[0197] Wherein (SM9) represents the triphenylene core, and (P9) represents the triphenylene derivative;

[0198] A independently represents a hydrogen atom, an aryl group, an alkyl group containing 1 to 20 carbons (e.g., 1 to 15 carbons, or 1 to 10 carbons, or 10, 9, 8, 7, 6, 5, 4, 3, 2 or 1 carbon);

[0199] J independently represents a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, a carbon atom, an oxygen atom (e.g., an alkylated oxygen atom), a nitrogen atom (e.g., an alkylated nitrogen atom), a cyano group, a nitro group, an alkyl group and / or an aryl group (e.g., a phenol group).

[0200] G independently represents a substituted carbon atom;

[0201] (E) represents the reagent;

[0202] R independently represents an aromatic group and / or an aliphatic group;

[0203] Z is one of an oxygen atom, a derived oxygen atom, a chlorine atom or a bromine atom;

[0204] And wherein the triphenylene core (SM9) and the reagent (E) undergo an intermolecular coupling reaction to produce a triphenylene derivative (P9).

[0205] The method of synthesizing a triphenylene derivative may include using a starting material having the formula:

[0206]

[0207] The method may further include a transition metal catalyst. The transition metal catalyst may be a rhodium-based catalyst. Additionally or alternatively, the transition metal catalyst may be a palladium (II) catalyst, such as palladium acetate.

[0208] The method may further comprise a reagent to displace the group Z in situ with a good leaving group.

[0209] The reagent (E) may be a carboxylic acid, such as benzoic acid or a substituted benzoic acid. Alternatively, the reagent (E) may be an acid chloride, such as benzyl chloride or a substituted benzyl chloride.

[0210] The method may comprise heating the triphenylene core to reflux in a solvent such as toluene in the presence of a palladium catalyst such as Pd(OAc)2, wherein compound (E) is a carboxylic acid, ie, Z is an OH group.

[0211] The method may further include a species for replacing group Z with a good leaving group, for example, the species may be (diacetoxyiodo)benzene).

[0212] Alternatively, the method may include heating the polycyclic aromatic hydrocarbon core, such as a triphenylene core, to reflux in a solvent such as toluene, wherein compound (E) is an acid chloride, ie, Z is a chlorine atom. The method may further include heating the reaction mixture to 240°C.

[0213] It should be understood that the polycyclic aromatic derivatives can be further functionalized to produce analogs. For example, the polycyclic aromatic hydrocarbon derivatives, such as triphenylene derivatives, can be brominated, such as using Br2 bromination, to add bromine atoms to one or more aromatic carbon atoms. The bromine atoms can be used as functional groups for further chemical transformations, such as functionalizing the polycyclic aromatic hydrocarbon derivatives with phenolic groups. In an embodiment, J can represent bromine atoms and / or phenolic groups. The bromine atoms and / or phenyl groups can be used to further functionalize the polycyclic aromatic hydrocarbon derivatives.

[0214] Additionally or alternatively, one or more alkoxy groups (e.g. OC5H 11 The alkyl group of a hydroxyl (eg phenol) group may be dealkylated to form a hydroxyl (eg phenol) group (eg using boron tribromide).

[0215] The polycyclic aromatic hydrocarbon derivatives can be used as biomarkers or biological probes.

[0216] In the scope of the present application, it is clearly intended that the various aspects, embodiments, examples and alternatives set forth in the preceding paragraphs, in the claims and / or in the following description and drawings, and in particular their individual features, can be adopted independently or in any combination. That is to say, the features of all embodiments and / or any embodiment can be combined in any manner and / or combination, unless these features are incompatible. In order to avoid doubt, the terms "may", "and / or", "for example", "such as" and any similar terms as used herein should be interpreted as non-restrictive, so that there is no need for any features described in this way. In fact, without departing from the scope of the present invention, any combination of optional features can be clearly envisioned, regardless of whether these features are clearly claimed for protection. The applicant reserves the right to change any initially submitted claims or to submit any new claims accordingly, including the right to modify any initially submitted claims to be subordinate to any other claims and / or to incorporate any features of any other claims, although initially not claimed for protection in this manner. BRIEF DESCRIPTION OF THE DRAWINGS

[0217] Embodiments of the present invention will now be described, by way of example only, with reference to the accompanying drawings, in which:

[0218] Figure 1 are representative structures of a series of triphenylene derivatives according to some embodiments of the present invention;

[0219] Figure 2 is a triphenylene derivative according to a first example of the present invention;

[0220] Figure 3 Is a synthetic Figure 2 The method of the triphenylene derivative of the first embodiment of the present invention is shown;

[0221] Figure 4 is a schematic synthesis route of the prior art of a precursor of a triphenylene derivative according to an embodiment of the present invention;

[0222] Figure 5A It is used to synthesize Figure 1 The schematic synthesis route of the triphenylene derivative according to the embodiment of the present invention is shown;

[0223] Figure 5B It is used to synthesize Figure 1 The schematic synthesis route of alternative triphenylene derivatives according to the embodiment of the present invention is shown;

[0224] Figure 6 is a schematic synthesis route of a precursor of a triphenylene derivative according to a further embodiment of the present invention;

[0225] Figure 7are examples of polycyclic aromatic hydrocarbon derivatives according to embodiments of the present invention;

[0226] Figure 8 are normalized absorption and emission spectra of triphenylene derivatives according to embodiments of the present invention;

[0227] Fig. 9 is the light emission of a solid-state triphenylene derivative according to some embodiments of the present invention;

[0228] Fig.10 is a graph showing DSC (differential scanning calorimetry) thermal analysis data of triphenylene derivatives according to some embodiments of the present invention;

[0229] Fig.11 According to some embodiments of the present invention

[0230] The data of the photoconductivity experiment on the triphenylene derivatives are shown in the example;

[0231] Fig.12 is a graphical data showing the conductivity of a triphenylene derivative according to one embodiment of the present invention;

[0232] Fig.13 is a graph showing the conductivity of a triphenylene derivative according to one embodiment of the present invention;

[0233] Fig.14 is a graph showing the conductivity of a triphenylene derivative according to one embodiment of the present invention;

[0234] Fig.15 is an OLED according to another aspect of the present invention;

[0235] Fig.16 This is the synthetic route according to Example 33 of the present invention. DETAILED DESCRIPTION

[0236] Reference now Figure 1 , shows representative structures of a triphenylene derivative series 100 according to some embodiments of the present invention. In this series, the R group is varied to provide analogs of the triphenylene derivative series 100. As described in more detail below, the R group can be selected to change the luminescent properties and / or other advantageous properties of the triphenylene derivative series 100.

[0237] Reference now Figure 2 , shows a triphenylene derivative 200, compound 1, according to one embodiment of the present invention. In this embodiment, the R group is an alkyl group of formula C4H9. Also refer to Figure 3, showing a schematic synthesis route 300 of compound 1. Two pathways for the rearrangement reaction of precursor 1, pathway A and pathway B, are shown, wherein precursor 1 is an azide (1-azido-2,3,6,7,10,11-hexa(pentyloxy)triphenylene), wherein the reaction conditions are heating in xylene at 175° C. in nitrogen for 16 hours. The inventors expected pathway B to be successful, wherein precursor 1 rearranges to produce carbazole 301. However, this was not observed. Instead, and unexpectedly, pathway A was observed, wherein precursor 1 rearranges to produce compound 1.

[0238] Without wishing to be bound by theory, it is believed that the reaction of precursor 1 in pathway A proceeds via an intramolecular ring closure mechanism leading to the formation of compound 1 in quantitative yield. No carbazole 301 product was observed. The method for synthesizing compound 1 is described below in Example 1. It should be noted that compound 1 is synthesized using an intramolecular approach. We have found that other alkyl analogs (e.g., C7, C8 analogs) can be prepared in a similar manner. Other embodiments of the present invention require different synthetic methods, which proceed via different chemical mechanisms.

[0239] Reference now Figure 4 , shows a schematic synthesis route 400 for the preparation of precursor 1 and in addition precursor 2 (which is an amine (2,3,6,7,10,11-hexa(pentyloxy)-1-triphenylamine)) and precursor 3 (which is an amine (2,3,6,7,10,11-hexa(butoxy)-1-triphenylamine)) of the prior art (N. Boden et al. J. Mater. Chem., 1995, 5, 2275). The entire procedure for synthesizing precursor 1, precursor 2 and precursor 3 starting from catechol 401 is found in the prior art and is incorporated herein by reference.

[0240] Reference now Figure 5A , which shows a schematic synthetic route 500A for forming the triphenylene derivative series 100 of the present invention. Precursor 2, carboxylic acid 501 and triphenylene derivative series 100 are shown. Carboxylic acid 501 contains an R group, which is introduced into the oxazole portion of the triphenylene derivative series 100. The R group can be an alkyl or aryl group, that is, the carbon atom bonded to the oxazole portion in the triphenylene derivative series 100 can be sp 2 or sp 3 Hybrid.

[0241] You can use it according to the following general procedure Figure 5AMethod 500A of the present invention is used to synthesize the triphenylene derivative series 100. A solution of the appropriate carboxylic acid (1.31 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.157 mmol) in PhMe (5 mL) is heated at 70°C for 20 minutes under N2. While stirring, a solution of precursor 2 (100 mg; 0.131 mmol) in PhMe (2 mL) is added and heated to reflux for 48-72 h. The solution is cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase is washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase is dried in vacuo. The crude black solid is then purified by flash column chromatography (silica, 40% CH2Cl2:60% n-hexane) to give the triphenylene derivative series 100.

[0242] This process is based on prior art methods for the formation of carbazoles (JA Jordan-Hore, CCC Johansson, M. Gulias, EM Beck, MJ Gaunt, J. Am. Chem. Soc., 2008, 130, 16184-16186.) and, as previously described, surprisingly enables the formation of triphenylene derivative series 100, ie, triphenylene oxazoles.

[0243] Also refer to Figure 5B , which shows a schematic synthetic route 500B for forming the triphenylene derivative series 100 of the present invention. Precursor 2, acid chloride 502, and triphenylene derivative series 100 are shown. Intermediate amide 100A is further shown. In this method, acid chloride 502 contains an R group, which is introduced into the oxazole portion of triphenylene derivative series 100. As Figure 5A As in method 500A, the R group can be an alkyl or aryl group, that is, the carbon atom bonded to the oxazole portion in the triphenylene derivative series 100 can be sp 2 or sp 3 Hybrid.

[0244] You can use it according to the following general procedure Figure 5BMethod 500B of the present invention is used to synthesize the triphenylene derivative series 100. A solution of precursor 2 or precursor 3 (100 mg; 0.132 mmol), the appropriate acid chloride (0.658 mmol) and triethylamine (0.574 mmol) in PhMe (5 mL) was heated to reflux under N2 for 18 hours while stirring. The resulting solution was further heated at 240°C for 15 minutes. The solution was cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to obtain the triphenylene derivative series 100.

[0245] Without wishing to be bound by theory, the inventors believe that the acid chloride 502 reacts with the precursor 2 to form an intermediate amide in situ ( Figure 5B 100A), which subsequently undergoes ring closure to form the triphenylene derivative series 100. Figure 3 In contrast to the compound 1 observed in the above, the reactions of method 500A and method 500B are both intermolecular coupling reactions of carboxylic acid or acyl chloride with precursor 2. When R = Ph, intermediate amide 100A has been prepared according to Figure 5B Separation method shown.

[0246] Advantageously, Figure 5A and Figure 5B The method enables Figure 5A The method 500A wherein the carboxylic acid 501 or Figure 5B The R group of the acyl chloride 502 in the method 500B of the present invention is used to synthesize a large number of analogs of triphenylene derivatives 100. The triphenylene derivative series 100 of the present invention show many desired properties, particularly desired luminescent properties. Advantageously, the R group can be changed to "adjust" these properties. More advantageously, within the known parameters of the present invention, the R group can be specifically selected so that the desired luminescent properties can be "adjusted". This is described in detail in the following section.

[0247] Reference now Figure 6 , shows a schematic synthetic route 600 for producing precursor 4 (which is an amine). When R'=C5H 11 When the precursor 4 is 2,3,6,7,10,11-hexa(pentyloxy)-1,8-triphenylamine. Precursor 4 is synthesized from dinitrobenzophenanthrene 601. Figure 4 In the prior art process of (shown in FIG. 1 ), dinitrotriphenylene 601 is formed as a by-product. Dinitrotriphenylene 601 can be isolated as an earlier fraction than the mononitro intermediate 404 using flash column chromatography.

[0248] To further illustrate the present invention, reference is also made to the following non-limiting examples.

[0249] All compound names were generated using ChemDraw (RTM) software.

[0250] refer to Figure 7 , which shows an example of triphenylene derivative series 100 (Compound 2-26). The method for synthesizing Compound 2-26 is described below.

[0251] Example 1 - Method for synthesizing compound 1

[0252] Compound 1 was synthesized using the following method. A solution of precursor 1 (100 mg; 0.13 mmol) in o-xylene (8 mL) was added to a flask. It was then heated and maintained at 175° C. for 16 hours to provide compound 1 (51% yield).

[0253] In an alternative, compound 1 was synthesized using the following method. A solution of precursor 1 (100 mg; 0.13 mmol) in dry PhMe (8 mL) was added to a flask containing rhodium octanoate dimer (8 mg; 0.01 mmol) under N2 atmosphere. It was then heated and kept at reflux for 20 hours. The reaction was cooled to room temperature and then evaporated to dryness in vacuo, and the solid was then purified by flash column chromatography (silica, 95% hexane: 5% ethyl acetate) to give compound 1 as a white solid (96 mg, 99%).

[0254] The name of compound 1 is 8-butyl-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0255] Compound 1 has the following characterization data: 1 ΗΝMR(300ΜΗz,CDCl3)δH:10.01(1H,s),7.94(1H,s),7.90(1H,s),7.88(1H,s),7.85(1H,s),4.42(2H,t,J6.7Hz),4.37(2H,t,J 6.7Hz)4.29–4.23(6H,m),3.09(2H,t,J 7.5Hz),2.05–1.92(10H,m),1.62–1.43(24H,m),1.06–0.96(18H,m)ppm. 13C NMR (100MHz, CDCl3) δC: 165.6,149.5,149.1,148.7,148.3,142.9,140.1,139.8,124.6,123.9,123.5,123.3,116.3, 111.0,108.3,106.9,106.8,102.6,69.9,69.6,69.5,68.8,29.2,29.0,28.8,28.4,28.3,22.6,22.4,14.2,13.9ppm. ES+MS m / z:756.5([M + H] + 15%),778.5([M + Na] + 100%). -1 (Net): 3112w(CH), 2953m(CH), 1617w(C=N), 1517w(benzene ring), 1259s(CO), 1177s(CO), 1159s(CO)cm-1. Elemental analysis found: C, 76.09; H, 9.17; N, 1.95. 48 H 69 NO6 requires C, 76.25; H, 9.20; N, 1.85%.

[0256] Example 2 - Method for Synthesizing Compound 2

[0257] Compound 2 was synthesized using the following method. A slurry of benzoic acid (160 mg; 1.31 mmol), palladium diacetate (0.005 mmol) and iodobenzene diacetate (0.16 mmol) in PhMe (5 mL) was heated at 70 ° C for 20 minutes under N2. Precursor 2 (100 mg, 0.13 mmol) in PhMe (2 mL) was added and the reaction was heated and kept at reflux for 72 h. The mixture was cooled to room temperature and diluted with CH2Cl2 (20 mL). The mixture was washed with 1 M NaOH (2×20 mL) and the organic phase was dried in vacuo. The crude black solid was purified by flash column chromatography (60% n-hexane: 40% CH2Cl2) to give compound 2 as a white solid (35 mg; 34%).

[0258] The name of compound 2 is 2,3,6,11,12-penta(pentyloxy)-8-phenyltriphenylene[1,2-d]oxazole.

[0259] Compound 2 has the following characterization data: 1ΗΝMR(300ΜΗz,CDCl3)δH:10.13(1H,s),8.40-8.37(2H,m),7.92(1H,s),7.88(1H,s),7.87(1H,s),7.77(1H,s),7.57-7.55(1H, m),4.48–4.43(4H,m),4.30–4.23(6H,m),2.12–1.92(10H,m),1.69–1.54(12H,m),1.53–1.45(12H,m),1.04–0.96(18H,m)ppm. 13 C NMR (100MHz, CDCl3) δC: 161.4, 149.5, 149.0, 148.7, 148.3, 142.9, 140.5, 140.2, 131.2, 128.9, 127.5, 127.1, 124.7, 123. 8,123.4,123.3,116.4,110.9,108.2,106.8,106.6,103.8,69.8,69.5,68.9,29.2,29.0,28.4,28.3,22.6,22.6,14.1ppm. ES+MS m / z: 775.5 ([M] + 22%), 776.5 ([M + H] + 37%), 798.5 ([M + Na] + 100%). Elemental analysis found: C, 77.46; H, 8.44; N, 1.75%. 50 H 65 NO6 requires C, 77.38; H, 8.44; N, 1.80%.

[0260] Example 3 - Method for synthesizing compound 3

[0261] Compound 3 was synthesized using the following method. A solution of 2-naphthoic acid (225 mg; 1.31 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.157 mmol) in PhMe (5 mL) was heated at 70° C. for 20 minutes under N2. While stirring, a solution of precursor 2 (100 mg; 0.131 mmol) in PhMe (2 mL) was added and heated to reflux for 48-72 h. The solution was cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 3 as a yellow solid (35 mg, 32%).

[0262] The name of compound 3 is 8-(naphthalen-2-yl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0263] Compound 3 has the following characterization data: 1 ΗΝMR(300ΜΗz,CDCl3)δH:10.22(1H,s),8.89(1H,s),8.49(1H,dd,J 8.6,1.7),8.05–7.99(2H,m),7.96-7.91(5H,m),7.62–7.59(2H,m),4.54(2H,t,J 6.8),4.51(2H,t,J 6.8),4.32–4.25(6H,m),2.17–1.93(10H,m),1.76–1.42(20H,m),1.06–0.97(15H,m)ppm. 13 C NMR(100MHz, CDCl3)δC:161.7,149.8,149.3,149.0,148.6,143.2,140.9,140 .6,135.0,133.4,129.3,128.9,128.3,128.0,127.9,127.4,127.2,125.0,125 .0,124.4,124.2,123.7,123.6,116.7,111.2,108.5,107.1,107.0,103.9,70.2,70.1,69.8,69.2,29.6,29.5,28.9,28.8,28.7,23.1,23.0,14.6,14.5 ppm. MALDI+ m / z: 825.5 ([M]+100%). IRλ-1 (net): elemental analysis found: C, 78.95; H, 8.02; N, 1.83%. C 54 H 67 NO6 requires C, 78.51; H, 8.17; N, 1.70%.

[0264] Example 4-Synthesis of Compound 4

[0265] Compound 4 was synthesized using the following method. A solution of 1-naphthoic acid (225 mg; 1.31 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.157 mmol) in PhMe (5 mL) was heated at 70° C. for 20 minutes under N2. While stirring, a solution of precursor 2 (100 mg; 0.131 mmol) in PhMe (2 mL) was added and heated to reflux for 48-72 h. The solution was cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 4 as a yellow solid (24 mg, 22%).

[0266] The name of compound 4 is 8-(naphthalen-1-yl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0267] Compound 4 has the following characterization data: 1 ΗΝMR(300ΜΗz,CDCl3)δH:10.15(1H,s),9.82(1H,d,J 8.3Hz),8.59(1H,dd,J 7.3,1.2Hz),8.08(1H,d,J 8.3Hz),8.01-7.98(3H,m),7.94(2H,m),7.71-7.61(3H,m),4.54-4.45(4H,m),4. 32-4.26(6H,m),2.10-1.94(10H,m),1.70-1.35(20H,m),1.04–0.87(15H,m)ppm. 13 C NMR (100MHz, CDCl3) δC: 161.3, 149.9, 149.6, 149.1, 148.8, 143.2, 141.0, 139.9, 134.5, 132.4, 131.0, 129.6, 129.2, 127.8, 127.5, 126.9, 126. 7,125.5,125.0,124.2,124.1,123.8,117.0,111.0,108.6,107.3,107. 2,104.4,70.2,69.9,69.1,29.6,29.5,29.0,28.8,28.7,23.0,14.5ppm. MALDI+m / z: 826.7 ([M+H]+100%). Elemental analysis found values: C, 78.49; H, 8.23; N, 1.73%. 54 H 67NO6 requires C, 78.51; H, 8.17; N, 1.70%.

[0268] Example 5 - Synthesis of Compound 5

[0269] Compound 5 was synthesized using the following method. A solution of 2-anthracenecarboxylic acid (290 mg; 1.31 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.157 mmol) in PhMe (5 mL) was heated at 70° C. for 20 minutes under N2. While stirring, a solution of precursor 2 (100 mg; 0.131 mmol) in PhMe (2 mL) was added and heated to reflux for 48-72 h. The solution was cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 5 as a yellow solid (22 mg, 20%).

[0270] The name of compound 5 is 8-(anthracen-2-yl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0271] Compound 5 has the following characterization data: 1 ΗΝMR(300ΜΗz,CDCl3)δH:10.20(1H,s),9.00(1H,s),8.58(1H,s),8.4 7(1H,s),8.39(1H,dd,J8.9,1.6Hz)8.13-8.10(2H,m),8.07-8.02(2H ,m),7.93(1H,s),7.90-7.89(3H,m),4.57-4.47(4H,m),4.31-4.24(6 H,m),2.19-1.96(10H,m),1.76-1.44(20H,m),1.08–0.97(15H,m)ppm. 13C NMR (100MHz, CDCl3)δC:161.8,149.8,149.4,149.0,148.6,143.2,141.0,140.6,133.1,132.6,132.3,131.2,129.2,128.7128.6,128.2 127.4,126.8,126.6,126.3,125.0,124.4,124.2,123.8,123.6,116.7,111.3,108.5,107.1,107.0,104.0,70.2,70.1,69.8,69.2,30.1,29.6,29.5,28.9,28.8,28.7,23.1,23.0,14.7,14.5ppm. MALDI+m / z:876.5([M+H]+100%). Elemental analysis found: C,79.49; H,7.88; N,1.51. C 58 H 69 NO6 requires C, 79.51; H, 7.94; N, 1.60%.

[0272] Example 6-Synthesis of Compound 6

[0273] Compound 6 was synthesized using the following method. A solution of 9-anthracenecarboxylic acid (290 mg; 1.31 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.157 mmol) in o-xylene (5 mL) was heated to 70° C. for 20 minutes under N2. A solution of precursor 2 (100 mg; 0.131 mmol) in o-xylene (2 mL) was added and heated to 140° C. for 72 h. The mixture was cooled to room temperature and diluted with CH2Cl2 (20 mL). The mixture was washed with 1M NaOH (2×20 mL) and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 6 as a yellow solid (13 mg, 11%).

[0274] The name of compound 6 is 8-(anthracen-9-yl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0275] Compound 6 has the following characterization data: 1ΗΝMR(300ΜHz,CDCl3)δH:10.18(1H,s),8.70(1H,s),8.49-8.44(2H,m),8.15-8.09(2H ,m),8.03(1H,s)8.02(1H,s)7.95(1H,s),7.94(1H,s)7.58-7.52(4H,m),4.50(2H,t,J 6.7Hz),4.33-4.27(6H,m),4.17(2H,t,J 6.7Hz),2.05-1.93(8H,m),1.79(2H,p,J 6.7,1.0Hz)1.66-1.37(20H,m),1.03–0.92(15H,m)ppm. 13 CNMRδC: (100MHz, CDCl3)160.6,150.0,149.6,149.2,148.8,143.5,141.0,1 40.7,131.9,131.7,131.3,129.1,127.7,127.6,126.4,125.9124.2,123.8,1 21.1,117.1,111.3,108.7,107.3,107.2,104.6,70.4,70.3,69.9,69.2,29. 6,29.5,29.0,28.8,28.7,28.6,28.5,23.0,22.9,22.6,14.5,14.4,14.3ppm. MALDI + m / z:876.5([M+H] + 100%). Elemental analysis measured values: C, 79.13; H, 7.83; N, 1.77%. 58 H 69 NO6 requires C, 79.51; H, 7.94; N, 1.60%.

[0276] Example 7-Synthesis of Compound 7

[0277] Compound 7 was synthesized using the following method. A solution of 4-fluorobenzoic acid (187 mg; 1.31 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.157 mmol) in o-xylene (5 mL) was heated to 70° C. for 20 minutes under N2. A solution of precursor 2 (100 mg; 0.131 mmol) in o-xylene (2 mL) was added and heated to 140° C. for 72 h. The mixture was cooled to room temperature and diluted with CH2Cl2 (20 mL). The mixture was washed with 1M NaOH (2×20 mL) and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 7 as a yellow solid (13 mg, 9%).

[0278] The name of compound 7 is 8-(4-fluorophenyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0279] Compound 7 has the following characterization data: 1 ΗΝMR(300ΜΗz; CDCl3)δH:10.03(s,1H),8.36–8.30(m,2H),7.97–7.75(m,4H),7.28–7.15(m,3H ),4.41(t,J=6.6Hz,4H),4.26(m,6H),2.06–1.90(m,9H),1.55(m,22H),1.05–0.95(m,15H)ppm. 13 C NMR (100MHz; CDCl3) δC: 166.0,163.5,160.6,149.7,149.1,148.9,148.5,143.0,140.5,140.3,129.8,129.7,127.3,124.8,123.9,123.8,123.5 ,116.5,116.3,116.1,111.1,108.4,107.0,106.8,103.7,69.9,69.8,69 .7,69.5,68.9,29.7,29.2,29.0,28.5,28.4,28.3,22.6,14.2,14.1ppm. 19 F NMR (282MHz, CDCl3) δF: -108.0ppm. MALDI+m / z:795.6([M+H+1] + 15%)),794.6([M+H] + 55%),793.6([M]+100%). IRλ -1(Net): 2952m(CH), 2926m(CH), 2858m(CH), 1616w(C=N), 1517s(benzene ring), 1499m(benzene ring), 1433m(benzene ring), 1261m(CO), 1174s(CO)cm -1 .

[0280] Example 8-Synthesis of Compound 8

[0281] Compound 8 was synthesized using the following method. A solution of 3-fluorobenzoic acid (182 mg; 1.30 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.157 mmol) in o-xylene (5 mL) was heated to 70° C. for 20 minutes under N2. A solution of precursor 2 (100 mg; 0.131 mmol) in o-xylene (2 mL) was added and heated to 140° C. for 72 h. The mixture was cooled to room temperature and diluted with CH2Cl2 (20 mL). The mixture was washed with 1 M NaOH (2×20 mL), and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 8 as a yellow solid (13 mg, 11%).

[0282] The name of compound 8 is 8-(3-fluorophenyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0283] Compound 8 has the following characterization data: 1 ΗNMR (300ΜΗz; CDCl3) δH: 10.06 (s, 1H), 8.15 (d, J = 7.9Hz, 1H), 8.05 (dd, J = 9.0, 1.9Hz, 1H), 7.89 (m, 4H), 7.53 (m, 1H) ,7.36–7.16(m,4H),4.45(m,4H),4.33–4.21(m,6H),2.16–1.90(m,11H),1.71–1.39(m,24H),1.06–0.93(m,15H)ppm. 13C NMR(100MHz; CDCl3)δC:164.3,161.8,160.1,160.1,149.6,149.1,148.8,148.4, 142.9,140.3,140.3,130.6,130.5,129.6,129.6,127.3,124.8,123.7,123.4,123 .4,123.2,123.2,118.3,118.1,116.4,114.6,114.3,110.9,108.2,106.8,106.7, 103.9,69.9,69.8,69.6,69.0,29.4,29.3,29.2,28.6,28.5,28.4,22.8,14.3ppm. 19F NMR (282MHz; CDCl3) δF: -111.8ppm. ES+MS m / z:817.5([M+H + Na] + 50%),816.5([M+Na] + 100%), 794.5 ([M] + 55%). IRλ-1 (net): 2952m (CH), 2925m (CH), 2856m (CH), 1617w (C=N), 1518s (benzene ring), 1434s (benzene ring), 1262s (CO), 1174s (CO) cm-1. Elemental analysis found: C, 75.62; H, 8.25; N, 1.78%. C 50 H 64 FNO6 requires C, 75.63; H, 8.12; N, 1.76%.

[0284] Example 9-Synthesis of Compound 9

[0285] Compound 9 was synthesized using the following method. A solution of 2-fluorobenzoic acid (41.86 mg; 0.26 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.157 mmol) in o-xylene (5 mL) was heated to 70° C. for 20 minutes under N2. A solution of precursor 2 (100 mg; 0.131 mmol) in o-xylene (2 mL) was added and heated to 140° C. for 72 h. The mixture was cooled to room temperature and diluted with CH2Cl2 (20 mL). The mixture was washed with 1M NaOH (2×20 mL) and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 9 as a yellow solid (7 mg, 10%).

[0286] The name of compound 9 is 8-(2-fluorophenyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0287] Compound 9 has the following characterization data: 1H NMR (300 MHz; CDCl3) δH: 10.16 (s, 1H), 8.38 (m, 1H), 7.92 (m, 4H), 7.63-7.47 (m, 1H), 7.43-7.28 (m, 2H), 4.47 (m, 4H), 4.27 (m, 5H), 2.13-1.91 (m, 9H), 1.69-1.39 (m, 21H), 1.00 (m, 14H) ppm. 13C NMR (100MHz; CDCl3) δC:162.4,159.8,157.6,157.5,149.7,149.3,148.8,14 8.4,142.9,140.6,140.5,139.9,132.9,132.8,130.3,127.3,124.8,124.5,1 23.9,123.4,123.4,117.4,117.2,116.7,116.0,115.9,110.9,108.3,107.0, 106.9,104.4,69.8,69.5,68.9,29.2,29.0,28.4,28.3,22.6,22.6,14.1ppm. 19F NMR (282MHz; CDCl3) δF: -109.1ppm. MALDI+m / z: 795.6([M+1+H]+20%), 794.6([M+H]+65%), 793.6([M]+100%). IRλ-1(net):2952m(CH),2925m(CH),2856m(CH),1617w(C=N),1518m(benzene ring),1434m(benzene ring),1261s(CO),1176s(CO)cm-1. Elemental analysis measured values: C,75.92; H,8.26; N,1.74%. 50 H 64 FNO6 requires C, 75.63; H, 8.12; N, 1.76%.

[0288] Example 10 - Synthesis of Compound 10

[0289] Compound 10 was synthesized using the following method. A slurry of precursor 2 (100 mg; 0.01 mmol), iodobenzene diacetate (51 mg; 0.16 mmol) and palladium diacetate (1 mg; 0.005 mmol) in a mixture of PhMe (5 mL) and acetic acid (1 mL) in PhMe (5 mL) was heated and maintained at reflux for 72 hours under N2 atmosphere. The reaction was then cooled to room temperature and washed with 1M NaOH (1 M; 2×10 mL). The organic phase was evaporated to dryness under vacuum. The solid was then purified by flash column chromatography (60% n-hexane: 40% CH2Cl2) to give compound 10 as a white solid (64 mg; 66%).

[0290] The name of compound 10 is 8-methyl-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0291] Compound 10 has the following characterization data: 1H NMR δH: (400 MHz, CDCl3) 9.94 (1H, s), 7.94 (1H, s), 7.90 (1H, s), 7.89 (1H, s), 7.85 (1H, s), 4.42 (2H, t, J 6.7), 4.38 (2H, t, J 6.8), 4.30–4.24 (6H, m), 2.81 (3H, s), 1.99 (10H, m), 1.65–1.53 (10H, m), 1.52–1.44 (10H, m), 1.03–0.96 (15H, m) ppm. 13C NMRδC: (100MHz, CDCl3)162.4,149.9,149.4,149.1,148.8,143.2,140.8,140.2,127.2,125.0,124.2,123.9,123.7,116. 7,111.6,108.8,107.3,107.2,102.9,70.3,70.2,69.88,69.40,29.60,29.5,29.3,28.8,28.8,28.6,23.0,15.2,14.5ppm. MALDI m / z:714.5([M]+100%).

[0292] Example 11 - Synthesis of Compound 11

[0293] Compound 11 was synthesized using the following method. A solution of precursor 2 (200 mg, 0.263 mmol) and trimethylamine (0.2 mL, 1.44 mmol) in PhMe (7 mL) was heated to reflux for 10 minutes under N2. 2-Thiophenecarbonyl chloride (0.3 mL, 2.62 mmol) was added and heated to reflux for 90 minutes. The solution was cooled to room temperature, washed with 1M HCl (30 mL), and the organic phase was extracted with EtOAc (2×30 mL). The organic phase was dried in vacuo, and the resulting black solid was heated at 240° C. for 10 minutes before cooling to room temperature. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 11 as a yellow solid (136 mg, 64%).

[0294] The name of compound 11 is 2,3,6,11,12-penta(pentyloxy)-8-(thiophen-2-yl)triphenylene[1,2-d]oxazole.

[0295] Compound 11 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.03(1H,s),7.99(1H,dd,J 3.7,1.2),7.92(1H,s),7.89(1H,s),7.88(1H,s),7.88(1H,s),7.58(1H,dd J 5.0,1.2),7.25-7.22(1H,dd,J 5.0,3.7),4.48-4.43(4H,m),4.31-4.23(6H,m),2.14-1.93(10H,m),1.71-1.42(20H,m),1.04-0.97(15H,m)ppm. 13C NMRδC: (100MHz, CDCl3)157.8,149.8,149.4,149.0,148.6,143.0,140.7 ,140.1,130.6,130.1,129.7,128.5,127.5,125.0,124.1,123.7,123.6,1 16.6,111.1,108.5,107.1,107.1,104.0,70.2,70.2,70.1,69.8,69.1,2 9.6,29.5,29.4,28.9,28.8,28.8,28.6,23.0,23.0,14.6,14.5,14.5ppm. MALDI m / z:781.5([M]+100%).

[0296] Example 12 - Synthesis of Compound 12

[0297] Compound 12 was synthesized using the following method. A solution of precursor 2 (100 mg, 0.132 mmol), 4-cyanobenzoyl chloride (109 mg, 0.658 mmol) and N,N-diisopropylethylamine (0.1 mL, 0.574 mmol) in PhMe (5 mL) was heated to and maintained at reflux for 18 hours under N2. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. The solid was then heated and maintained at 240 ° C for 15 minutes under N2. The crude black solid was then cooled to room temperature and purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 12 as a yellow solid (40 mg, 38%).

[0298] The name of compound 12 is 4-(2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazol-8-yl)benzonitrile.

[0299] Compound 12 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)9.96(1H,s),8.43-8.40(2H,d,J 8.55),7.90(1H,s),7.89(1H,s),7.88(1H,s),7.87(1H,s),7.83-7.80(2H,d,J8.55),4.43-4. 38(4H,m),4.30-4.23(6H,m),2.12-1.93(10H,m),1.67-1.42(20H,m),1.04-0.97(15H,m)ppm. 13 C NMRδC: (100MHz, CDCl3)159.3,150.0,149.3,149.1,148.8,143.1,140.6,140.4,132.7,131.4,127.8,127.6,125.0,123.7,123.7,123.4,118.7 ,116.6,114.4,111.0,108.4,106.9,106.7,104.4,70.2,70.0,69.9,69 .8,69.2,29.6,29.5,29.4,28.8,28.8,28.8,28.7,23.0,14.6,14.5ppm. MALDI m / z:800.4([M]+100%).

[0300] Example 13 - Synthesis of Compound 13

[0301] Compound 13 was synthesized using the following method. A solution of 4-(trifluoromethyl)benzoic acid carboxylic acid (248 mg; 1.31 mmol), palladium diacetate (0.005 mmol) and iodobenzene diacetate (0.157 mmol) in PhMe (5 mL) was heated at 60° C. for 30 minutes under N2. While stirring, a solution of precursor 2 (100 mg; 0.132 mmol) in PhMe (2 mL) was added and heated to reflux for 48-72 h. The solution was cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 13 as a yellow solid (6 mg, 5%).

[0302] The name of compound 13 is 2,3,6,11,12-penta(pentyloxy)-8-(4-(trifluoromethyl)phenyl)triphenylene[1,2-d]oxazole.

[0303] Compound 13 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.04(1H,s),8.48-8.46(2H,d,J 8.50),7.92(1H,s),7.90(1H,s),7.89(1H,s),7.88(1H,s),7.83-7.80(2H,d,J 8.50),4.47-4.45(4H,t,J 6.74),4.31-4.24(6H,m),2.14-1.94(10H,m),1.70-1.43(20H,m),1.05-0.98(15H,m)ppm. 19 F NMRδF: (300MHz, CDCl3) 62.9 (s) ppm. 13 C NMRδC: (100MHz, CDCl3)159.3,150.0,149.3,149.1,148.8,143.1,140.6,140.4,132.7,131.4,127.8,127.6,125.0,123.7,123.7,123.4,118.7 ,116.6,114.4,111.0,108.4,106.9,106.7,104.4,70.2,70.0,69.9,69 .8,69.2,29.6,29.5,29.4,28.8,28.8,28.8,28.7,23.0,14.6,14.5ppm. MALDI m / z:844.5([M+H]+100%).

[0304] Example 14 - Synthesis of Compound 14

[0305] Compound 14 was synthesized using the following method. A solution of precursor 2 (100 mg, 0.132 mmol), 2-iodobenzoyl chloride (175 mg, 0.658 mmol) and N,N-diisopropylethylamine (0.1 mL, 0.574 mmol) in PhMe (5 mL) was heated to and maintained at reflux for 18 hours under N2. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. The solid was then heated and maintained at 240 ° C for 15 minutes under N2. The crude black solid was then cooled to room temperature and purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 14 as a yellow solid (39.9 mg, 35%).

[0306] The name of compound 14 is 8-(2-iodophenyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0307] Compound 14 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.07(1H,s),8.20-8.16(1H,dd,J 7.90,1.60),8.18-8.15(1H,dd,J 7.90,1.25),7.95(1H,s),7.94(1H,s),7.91(2H,m),7.58-7.53(1H,td,J 7.66,7.63,1.25),7.26-7.20(1H,td,J 7.66,7.63,1.60),4.52-4.44(4H,m),4.31-4.25(6H,m),2.06-1.94(10H,m),1.67-1.41(20H,m),1.03-0.92(15H,m)ppm. 13 CNMRδC: (100MHz, CDCl3)160.9,149.9,149.6,149.2,149.1,143.3,142.0 ,140.6,140.4,132.5,132.1,132.1,128.5,127.6,125.1,124.1,124.0,1 23.7,117.2,111.9,108.6,107.3,107.1,104.9,95.0,70.4,70.2,70.2,7 0.1,69.9,29.6,29.6,29.5,29.5,28.9,28.8,28.7,23.0,23.0,14.5ppm. MALDI m / z: 901.6 ([M] +14%).

[0308] Example 15 - Synthesis of Compound 15

[0309] Compound 15 was synthesized using the following method. A solution of precursor 2 (100 mg, 0.132 mmol), 2-chlorobenzoyl chloride (175 mg, 0.658 mmol) and N,N-diisopropylethylamine (0.1 mL, 0.574 mmol) in PhMe (5 mL) was heated to and maintained at reflux for 18 hours under N2. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. The solid was then heated and maintained at 240 ° C for 15 minutes under N2. The crude black solid was then cooled to room temperature and purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 15 as a yellow solid (52.4 mg, 49%).

[0310] The name of compound 15 is 8-(2-chlorophenyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0311] Compound 15 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.06(1H,s),8.39-8.34(1H,m),7.92-7.90(4H,m),7.66(1H,m),7.51-7.44(2H, m),4.49-4.41(4H,m),4.30-4.25(6H,m),2.06-1.95(10H,m),1.67-1.43(20H,m),1.03-0.92(15H,m)ppm. 13 C NMRδC: (100MHz, CDCl3)158.8,149.6,149.4,148.9,148.5,142.9,140.4,139.9,133.5,131.7,131.6,127.3,127.0,126.2,124.8, 123.9,123.4,116.8,110.9,108.2,106.9,104.6,70.1,70.0,69.9,69.6,69.1,29.8,29.3,29.3,29.2,28.5,28.4,22.7,14.3ppm. MALDI m / z:809.7([M] + 95%).

[0312] Example 16 - Synthesis of Compound 16

[0313] Compound 16 was synthesized using the following method. A solution of precursor 2 (100 mg, 0.132 mmol), 2-bromobenzoyl chloride (144 mg, 0.658 mmol) and N,N-diisopropylethylamine (0.1 mL, 0.574 mmol) in PhMe (5 mL) was heated to and maintained at reflux for 18 hours under N2. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. The solid was then heated and maintained at 240 ° C for 15 minutes under N2. The crude black solid was then cooled to room temperature and purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 16 as a yellow solid (25.8 mg, 21%).

[0314] The name of compound 16 is 8-(2-bromophenyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0315] Compound 16 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.03(1H,s),8.31-8.28(1H,dd,J 7.91,1.75),7.91-7.89(4H,m),7.86-7.83(1H,dd,J 7.91,1.23),7.54-7.49(1H,td,J 7.70,7.60,1.23),7.42-7.37(1H,td,J 7.70,7.57,1.75)4.49-4.39(4H,m),4.31-4.23(6H,m),2.06-1.95(10H,m),1.64-1.43(20H,m),1.03-0.95(15H,m)ppm. 13 CNMRδC: (100MHz, CDCl3):159.5,149.7,149.4,148.9,148.6,142.9,140.3,135.0,132.2,131.8,128.3,127.6,127.4,124.8,123.9,12 3.6,123.5,122.0,116.9,111.1,108.2,107.0,104.7,70.1,70.0,69.9,69.6,69.4,29.3,29.3,29.2,28.6,28.5,28.4,22.7,14.3ppm. MALDI m / z:855.7([M] + 31%).

[0316] Example 17-Synthesis of Compound 17

[0317] Compound 17 was synthesized using the following method. A solution of 5-bromovaleric acid (773 mg; 4.27 mmol), palladium diacetate (0.005 mmol) and iodophenyl diacetate (0.512 mmol) in PhMe (10 mL) was heated at 70° C. for 20 minutes under N2. While stirring, a solution of precursor 2 (325 mg; 0.428 mmol) in PhMe (10 mL) was added and heated to reflux for 48-72 h. The solution was cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 17 as a white solid (109 mg, 31%).

[0318] The name of compound 17 is 8-(4-bromobutyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0319] Compound 17 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)9.95(1H,s),7.92(1H,s),7.90(1H,s),7.89(1H, s),7.84(1H,s),4.43-4.34(4H,m),4.30-4.24(6H,m),3.55-3.50(2H,t,J 6.29),3.15-3.10(2H,t,J 7.05),2.35(3H,s),2.25-1.94(12H,m),1.64-1.45(24H,m),1.03-0.97(15H,m)ppm. 13 C NMRδC: (100MHz, CDCl3)164.6,149.6,149.1,148.8,148.4,142.9,140.1,139.7,127.0,124.7,123.8,123.5,123.4,116.3,111.0,108.4,107. 0,102.7,70.0,69.9,69.6,69.6,68.9,33.0,31.9,29.3,29.2,29.2,29 .1,28.6,28.5,28.4,28.3,22.7,25.3,22.7,22.6,14.2,14.2,14.1ppm. ES+m / z: 834.4([M+H]+95%), 836.4([M+H]+100%).

[0320] Example 18 - Synthesis of Compound 18

[0321] Compound 18 was synthesized using the following method. A solution of compound 17 (66 mg, 0.079 mmol) in acetone (10 mL) was heated to 50° C. and stirred under N2, to which a solution of sodium azide (7 mg, 0.111 mmol) in water (5 mL) was added and stirred under N2 for 4 hours. Thereafter, a precipitate was formed, the solvent was removed under reduced pressure, and the precipitate was then vacuum filtered and dried to give compound 18 as an off-white solid (59 mg, 94%).

[0322] The name of compound 18 is 8-(4-azidobutyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0323] Compound 18 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)9.96(1H,s),7.94(1H,s),7.90(1H,s),7.90(1H,s),7.87(1H,s),4.45-4.40(2H,t,J 6.70),4.39-4.35(2H,t,J6.67),4.30-4.24(6H,m),3.55-3.51(2H,t,J6.31),3.17-3.12(2H,t,J 7.11),2.28-1.93(12H,m),1.65-1.41(24H,m),1.03-0.97(15H,m)ppm. 13 C NMRδC: (100MHz, CDCl3)165.0,149.6,149.9,149.4,149.1,148.7,143.2 ,140.4,140.0,127.3,125.0,124.1,123.8,123.7,116.7,111.3,108.7,1 07.3,103.0,70.3,70.3,69.9,69.9,69.2,33.3,32.3,29.6,29.5,29.5,2 9.4,28.9,28.8,28.7,28.6,28.0,25.6,23.0,23.0,14.6,14.5,14.5ppm. ES+m / z:819.5([M+Na]+100%).

[0324] Example 19-Synthesis of Compound 19

[0325] Compound 19 was synthesized using the following method. Compound 17 (21 mg, 0.025 mmol) was dissolved in anhydrous THF (4 mL), potassium thioacetate (12 mg, 0.1 mmol) was added to the mixture, and stirred for 6 hours under N2. The organic phase was then extracted with DCM (10 mL) and washed with water (2 × 10 mL). The organic phase was then dried in vacuo, and the solid was recrystallized from DCM: methanol (1 mL: 5 mL). The resulting precipitate was filtered by suction, and the solid was washed with methanol to give compound 19 as an off-white solid (4 mg, 19%).

[0326] The name of Compound 19 is S-(4-(2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazol-8-yl)butyl)thioacetate.

[0327] Compound 19 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)9.97(1H,s),7.94(1H,s),7.90(1H,s),7.89(1H, s),7.86(1H,s),4.45-4.35(4H,m),4.30-4.24(6H,m),3.14-3.09(2H,t,J 7.44),3.02-2.97(2H,t,J 7.21),2.35(3H,s),2.18-1.80(12H,m),1.65-1.42(24H,m),1.03-0.97(15H,m)ppm. 13 C NMRδC: (100MHz, CDCl3)196.0,165.2,149.9,149.4,149.1,148.7,143.2,140 .4,140.0,127.2,125.0,124.2,123.8,123.6,116.7,111.4,108.7,107.3,103 .1,70.3,70.2,69.9,69.9,69.2,31.0,30.1,29.6,29.5,29.5,29.4,29.4,29 .1,28.9,28.8,28.7,28.6,28.5,26.2,23.0,23.0,14.6,14.5,14.5,14.5ppm. MALDI m / z:829.5([M]+100%).

[0328] Example 20-Synthesis of Compound 20

[0329] Compound 22 was synthesized using the following method. A solution of compound 17 (260 mg, 0.311 mmol), sodium tert-butoxide (90 mg, 0.934 mmol), potassium iodide (40 mg, 0.311 mmol) and ethylene glycol (193 mg, 3.11 mmol) in MeCN (15 mL) was heated to and maintained at reflux for 48 hours under N2. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. The crude solid was dissolved with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL) and then HCl (1 M, 2x 20 mL), separated and the organic phase was dried in vacuo. The crude black solid was then cooled to room temperature and purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 16 as a yellow solid (84 mg, 36%).

[0330] The name of compound 20 is 8-(but-3-en-1-yl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0331] Compound 20 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.00(1H,s),7.92(1H,s),7.90(1H,s),7.89(1H,s),7.84(1H,s),6.14-6.00(1H,ddt,J 16.95,10.20,6.45),5.22(1H,dd,J 16.95,1.60),5.10(1H,dd,J10.20,1.60),4.43-4.35(4H,m),4.30-4.24(6H,m),3.22-3.17(2H,t,J 7.55),3.17-3.12(2H,t,J 7.11),2.86-2.78(2H,m),2.08-1.94(10H,m),1.62-1.45(20H,m),1.03-0.97(15H,m)ppm. 13C NMRδC: (100MHz, CDCl3)165.0,149.8,149.4,149.1,148.7,143.2,140.4, 140.0,137.0,127.2,125.0,124.2,123.8,123.6,116.7,116.3,111.4,10 8.7,107.3,107.2,103.0,70.3,70.2,69.9,69.9,69.2,30.9,29.6,29.5, 29.5,29.3,28.8,28.8,28.7,28.6,28.5,23.0,22.9,14.5,14.5,14.5ppm. ES+ m / z: 754.5 ([M+H]+100%).

[0332] Example 21-Synthesis of Compound 21

[0333] Compound 21 was synthesized using the following method. A solution of decanoic acid (0.132 mg; 0.236 mmol), palladium diacetate (0.005 mmol) and iodophenyl didecanoate (0.235 mmol) in PhMe (10 mL) was heated at 70° C. for 20 minutes under N2. While stirring, a solution of precursor 2 (100 mg; 0.132 mmol) in PhMe (10 mL) was added and heated to reflux for 48-72 h. The solution was cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase was dried in vacuo. The crude black solid was then purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 21 as a white solid (42 mg, 39%).

[0334] The name of compound 21 is 8-nonyl-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0335] Compound 21 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.02(1H,s),7.93(1H,s),7.90(1H,s),7.89(1H ,s),7.84(1H,s),4.43-4.36(4H,m),4.30-4.24(6H,m),3.11-3.06(2H,t,J 7.52),2.10-1.94(12H,m),1.63-1.29(32H,m),1.02-0.97(15H,m)0.91-0.87(3H,m)ppm. 13C NMRδC: (100MHz, CDCl3)165.9,149.8,149.3,149.0,148.6,143.2,140.4,140.1,127.1,124.9,124.2,123.8,123.6,1 23.6,116.6,111.3,108.6,107.2,107.1,102.9,70.2,69.9,69.8,69.1,32.3,29.9,29.8,29.7,29.6,29.5,29.4,29.0 28.9,28.8,28.6,27.123.1,23.0,14.5,14.5ppm. ES+m / z:826.6([M+H]+100%).

[0336] Example 22-Synthesis of Compound 22

[0337] Compound 22 was synthesized using the following method. A solution of precursor 2 (100 mg, 0.132 mmol), 4-(dimethylamino)benzoyl chloride (175 mg, 0.658 mmol) and N,N-diisopropylethylamine (0.1 mL, 0.574 mmol) in PhMe (5 mL) was heated to and maintained at reflux for 18 hours under N2. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. The solid was then heated and maintained at 240 ° C for 15 minutes under N2. The crude black solid was then cooled to room temperature and purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 22 as a yellow solid (19 mg, 18%).

[0338] The name of compound 22 is N,N-dimethyl-4-(2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazol-8-yl)aniline.

[0339] Compound 22 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.20(1H,s),8.27-8.24(2H,d,J 8.60),7.94(1H,s),7.90-7.85(3H,m),6.89-6.86(2H,d,J 8.60),4.56-4.45(4H,m),4.31-4.24(6H,m),3.11(6H,s),2.16-1.94(10H,m),1.71-1.42(20H,m),1.04-0.97(15H,m)ppm. 13C NMRδC: (100MHz, CDCl3)162.8,152.2,149.7,149.3,148.5,143.1,141.4,140.2,129.3,127.4,124.9,124.5,124.0,123.6,116.5,112.4,1 11.5,108.6,107.3,107.2,103.4,70.2,70.2,69.9,69.2,40.9,29.6 ,29.6,29.5,29.4,29.0,28.8,28.8,28.7,23.0,23.0,14.7,14.5ppm. ES+ m / z: 819.7 ([M]+100%).

[0340] Example 23 - Synthesis of Compound 23

[0341] Compound 23 was synthesized using the following method. A solution of 4-nitrobenzoic acid (1 g; 6 mmol), palladium diacetate (0.005 mmol) and (diacetoxyiodo)benzene (51 mg, 0.157 mmol) in PhMe (10 mL) was heated at 70° C. for 20 minutes under N2. While stirring, a solution of precursor 2 (100 mg; 0.132 mmol) in PhMe (10 mL) was added and heated to reflux for 48-72 h. The solution was cooled to room temperature and diluted with CH2Cl2 (20 mL). The organic phase was washed with aqueous NaOH (1 M; 2×20 mL), separated and the organic phase was dried in vacuo. The crude black solid was purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 23 as an off-white solid (74 mg, 69%).

[0342] The name of compound 23 is 8-(4-nitrophenyl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0343] Compound 23 has the following characterization data: 1ΗΝMRδH: (300MHz, CDCl3)9.66(1H,s),8.14-8.05(4H,m),7.74(1H,s),7.73(1H,s),7.70(1H,s), 7.67(1H,s),4.30-4.19(10H,m),2.04-1.94(10H,m),1.63-1.47(20H,m),1.05-1.00(15H,m)ppm. 13C NMRδC: (100MHz, CDCl3)158.9,150.0,149.3,149.1,148.8,143.0,140.6,140.4,132.8,127.8,127.5,125.0,124.0,123.6,123.5,123.3,1 16.5,110.8,108.3,106.8,106.4,104.3,70.2,69.9,69.8,69.7,69.1 ,29.6,29.6,29.5,29.4,28.9,28.8,28.8,28.7,23.0,14.6,14.5ppm. MALDI m / z:820.5([M]+100%).

[0344] Example 24-Synthesis of Compound 24

[0345] Compound 24 was synthesized using the following method. A solution of (diacetoxyiodo)benzene (51 mg, 0.157 mmol) and acetylsalicylic acid (550 mg, 3.031 mmol) in toluene (4 mL) was heated to 80 ° C and stirred for 10 minutes under N2. Precursor 2 (100 mg, 0.131 mmol) was then added to form a black solution, which was then stirred for another 10 minutes. A solution of diacetate palladium (1 mg, 5 mol%) and acetylsalicylic acid (553 mg, 3.197 mmol) in toluene (4 mL) was heated to 110 ° C and stirred for 10 minutes under N2 and then merged with the black solution. The resulting solution was stirred at 110 ° C under N2 for 72 hours. The crude black solution was dried in a vacuum and purified by flash column chromatography (silicon dioxide; 40% CH2Cl2: 60% n-hexane). The crude material was then evaporated to dryness in vacuo and then dissolved in a mixture of MeCN (10 mL) and 1M NaOH (10 mL). The solution was heated to 80°C for 2 hours. After cooling to room temperature, the product was acidified with 1M HCl (20 mL) and extracted into CH2Cl2 (3×10 mL). The combined organic layers were evaporated to dryness in vacuo to give compound 24 as a white solid (2 mg, 2%).

[0346] The name of compound 24 is 2-(2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazol-8-yl)phenol.

[0347] Compound 24 has the following characterization data: 1H NMR δH: (300 MHz, CDCl 3 ) 11.42 (1H, s), 9.35 (1H, s), 8.20-8.17 (1H, dd, J 8.01, 1.67), 7.90 (1H, s), 7.89 (1H, s), 7.88 (1H, s), 7.87 (1H, s), 7.52-7.46 (1H, ddd, J 8.51, 7.22, 1.67), 7.18-7.14 (1H, dd, J 8.51, 1.08), 7.08-7.05 (1H, ddd, J 8.01, 7.22, 1.08), 4.47-4.42 (2H, t, J 6.65),4.39-4.35(2H,t,J 6.71),4.30-4.19(6H,m),2.09-1.94(10H,m),1.71-1.43(20H,m),1.05-0.98(15H,m)ppm. MALDI m / z:791([M]+100%).

[0348] Example 25-Synthesis of Compound 25

[0349] Compound 25 was synthesized using the following method.

[0350] Precursor 3 was synthesized using the following method. A solution of 2,3,6,7,10,11-hexabutoxy-1-nitrotriphenylene (1.70 g, 2.79 mmol), sodium borohydride (1.70 g, 45.1 mmol) and nickel (II) chloride hexahydrate (4.45 g, 18.7 mmol) in a 50 / 50 mixture of MeOH and THF (40 mL) was stirred at room temperature under N2 for 5 hours. The crude black solid was then filtered and washed with CHCl3, and the filtrate was evaporated to dryness in vacuo to give Precursor 3 as a brown solid (1.6 g, 85%).

[0351] The name of precursor 3 is 2,3,6,7,10,11-hexabutoxytriphenylene-1-amine

[0352] Precursor 3 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)8.82(1H,s),7.83(1H,s),7.80(1H,s),7.78(1H,s),7.37(1H,s),4.5 7(2H,s),4.29-4.09(12H,m),2.01-1.81(12H,m),1.67-1.52(12H,m),1.13-0.94(18H,m)ppm. 13C NMRδC: (100MHz, CDCl3)151.0,149.5,148.9,148.0,147.6,138.4,135.6,127.0,124.7,124.5,124.1,124.0,114.0,110. 3,108.5,108.2,107.1,97.4,72.9,69.7,69.4,69.1,68.4,32.7,31.7,31.7,31.6,31.6,19.6,19.6,19.5,19.5,14.1ppm. MALDI m / z:675.8([M]+100%).

[0353] A solution of precursor 3 (100 mg, 0.148 mmol), 2-naphthoyl chloride (141 mg, 0.658 mmol) and N,N-diisopropylethylamine (0.1 mL, 0.574 mmol) in PhMe (5 mL) was heated to and maintained at reflux under N2 for 18 hours. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. The solid was then heated and maintained at 240 °C under N2 for 15 minutes. The crude black solid was then cooled to room temperature and purified by flash column chromatography (silica, 40% CH2Cl2: 60% n-hexane) to give compound 25 as a yellow solid (21 mg, 19%).

[0354] The name of compound 25 is 2,3,6,11,12-pentabutoxy-8-(naphthalen-2-yl)triphenylene[1,2-d]oxazole.

[0355] Compound 25 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.01(1H,s),8.68(1H,s),8.31-8.27(1H,dd,J 8.57,1.65),7.96-7.87(3H,m),7.80-7.79(3H,m),7.70(1H,s),7.58-7.55(2H,m),4.45-4.40(2H,t,J7.01),4.38-4.34(2H,t,J 6.67),4.28-4.19(6H,m),2.15-1.91(10H,m),1.79-1.59(10H,m),1.18-1.07(15H,m)ppm. 13C NMRδC: (100MHz, CDCl3)161.6,149.7,149.3,149.0,148.5,143.1,140.8 ,140.4,134.9,133.4,129.2,128.3,127.8,127.3,127.1,125.0,124.9, 124.4,124.1,123.7,123.6,116.6,111.3,108.4,107.1,106.9,103.7,6 9.8,69.6,69.5,68.9,31.9,31.9,19.9,19.8,19.8,14.5,14.4,14.4ppm. MALDI m / z:755.1([M]+100%).

[0356] Example 26-Synthesis of Compound 26

[0357] Compound 26 was synthesized using the following method. A solution of precursor 4 (135 mg, 0.174 mmol) and palladium diacetate (0.0005 mmol) in PhMe (7 mL) was heated to reflux for 10 minutes under N2. 2-Fluorobenzoyl chloride (0.02 mL, 0.174 mmol) was added and heated to reflux for 40 hours. The solution was cooled to room temperature and dried in a vacuum, and the resulting black solid was heated at 240 ° C for 10 minutes and then cooled to room temperature. The crude black solid was then purified by flash column chromatography (silicon dioxide, 40% CH2Cl2: 60% n-hexane) to obtain compound 26 as an off-white solid (6 mg, 4%).

[0358] The name of compound 26 is 2,9-bis(2-fluorophenyl)-4,7,12,13-tetrakis(pentyloxy)triphenylene[1,2-d:8,7-d′]bisoxazole.

[0359] Compound 26 has the following characterization data: 1 ΗΝMRδH: (300MHz, CDCl3)10.09(2H,s),8.38-8.32(2H,td,J 7.56,7.52,1.78),7.82(2H,m),7.58(2H,m),7.36-7.31(2H,m),7.29-7.25(2H,m) ,4.48-4.39(8H,m),2.16-1.96(8H,m),1.70-1.44(16H,m),1.05-1.00(12H,m)ppm. 19 F NMRδF: (300MHz, CDCl3) 108.9 (s) ppm. MALDI m / z:842.5([M]+100%).

[0360] Example 27-Synthesis of Compound 27

[0361] Compound 27 was synthesized using the following method. A solution of 4'-carboxybenzo-15-crown-5 (600 mg, 1.92 mmol), oxalyl chloride (2.0 mL, 23.6 mmol) and dimethylformamide (0.01 mL, 0.129 mmol) was heated and kept at reflux for 10 minutes under N2. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. A solution of precursor 2 (100 mg, 0.132 mmol) and N,N-diisopropylethylamine (0.1 mL, 0.574 mmol) in PhMe (5 mL) was added. The reaction was then heated and kept at reflux for 72 hours under N2. The reaction was cooled to room temperature and then evaporated to dryness in vacuo. The solid was then heated and kept at 240 °C under N2 for 15 minutes. The crude black solid was then cooled to room temperature and purified by flash column chromatography (silica, 10% EtOAc: 90% n-hexane) to afford compound 27 as a brown solid (22 mg, 17%).

[0362] The name of compound 27 is 8-(2,3,5,6,8,9,11,12-octahydrobenzo[b][1,4,7,10,13]pentaoxacyclopentadecin-15-yl)-2,3,6,11,12-penta(pentyloxy)triphenylene[1,2-d]oxazole.

[0363] Compound 27 has the following characterization data: 1H NMR δH: (300 MHz, CDCl 3 ) 10.10 (1H, s), 8.04-7.80 (6H, m), 6.99 (1H, d, J 8.35), 4.53-4.38 (4H, m), 4.33-4.17 (10H, m), 4.06-3.90 (4H, m), 3.89-3.73 (8H, m), 2.10-1.88 (10H, m), 1.69-1.44 (20H, m), 1.07-0.92 (15H, m) ppm. 13CNMRδC: (100MHz, CDCl3)161.6,152.1,149.6,149.1,148.9,148.4,142.9,140.7 ,140.1,127.2,124.7,124.0,123.6,123.4,121.7,120.5,116.4,113.2,112.9,1 11.1,108.3,107.0,103.4,71.3,70.6,70.5,70.0,70.0,69.9,69.6,69.5,69.2, 68.9,68.7,29.8,29.4,29.3,29.3,28.7,28.5,28.4,22.8,22.7,14.3,14.3ppm. MALDI m / z:965.9([M]+100%).

[0364] Example 28-Synthesis of Compound 28

[0365] Use the following method to synthesize compound 28.At -20 ℃, under nitrogen atmosphere, stir the solution of compound 2 (60mg, 0.077mmol) in degassed dichloromethane (5mL) in a 2-necked flask purged with nitrogen.By Suba-Seal (RTM) via syringe, add boron tribromide (1M dichloromethane solution, 387 μL, 0.385mmol, 5 equivalents), and the dark yellow solution is stirred at room temperature for 24 hours.Add water (40mL) to quench the reaction, and the product is extracted with dichloromethane (10mL), washed with water (2×20mL), and dried by MgSO4.The organic phase is evaporated to dryness, and purified by column chromatography (silicon dioxide: 5% ethyl acetate: hexane) to obtain compound 28, which is a brown solid (10mg, 6%).

[0366] The name of compound 28 is 2,3,11,12-tetrakis(pentyloxy)-8-phenyltriphenylene[1,2-d]oxazol-6-ol.

[0367] Compound 28 has the following characterization data: 1 HNMR(300MHz,CDCl3)δ Η:10.09(1H,s),8.48(2H,dd,J 6.86,2.85Hz),7.94(1H,s),7.90(1H,s),7.88(1H,s),7.83(1H,s),7.59–7.56(3H,m),5.95(1H,s br),4.48(2H,t,J 6.60Hz),4.33(2H,t,J 6.51Hz),4.26–4.24(4H,m),2.06–1.93(8H,m),1.64–1.43(16H,m),1.01–0.97(12H,m)ppm. ES + MS m / z:728.39([M+Na] + 25%)),707.41([M+H+1] + 30%)),706.41([M+H] + 85%).

[0368] Example 29-Synthesis of Compound 29

[0369] Compound 29 was synthesized using the following method. Compound 2 (250 mg, 0.322 mmol) was dissolved in dry dichloromethane (10 mL) and stirred at 0 ° C under a nitrogen atmosphere. Then 0.01 M solution (4 × 36 mL) of Br2 in dichloromethane (144 mL, 1.449 mmol) was added within 2 hours and monitored by TLC. The reaction was quenched by adding a saturated sodium metabisulfite solution (100 mL). The product was extracted with dichloromethane (30 mL), washed with water (3 × 30), dried and evaporated to dryness with MgSO4. The crude product was then purified by column chromatography (silicon dioxide 40% dichloromethane: hexane) to obtain compound 29 as a yellow solid (170 mg, 62%).

[0370] The name of compound 29 is 1-bromo-2,3,6,11,12-penta(pentyloxy)-8-phenyltriphenylene[1,2-d]oxazole.

[0371] Compound 29 has the following characterization data: 1H NMR (300 MHz, CDCl3) δ Η :10.06(1H,s),8.71(1H,s),8.56(1H,s),8.34–8.31(2H,m),7.60–7.58(4H,m),4.59(2H,t J 6.5Hz),4.41(2H,t J 6.8Hz),4.26–4.20(6H,m),2.06–1.90(10H,m),1.64–1.42(20H,m),1.02–0.94(15H,m)ppm.

[0372] Example 30-Synthesis of Compound 30

[0373] Compound 30 was synthesized using the following method. Under a nitrogen atmosphere, compound 29 (170 mg, 0.199 mmol), K2CO3 (410 mg, 2.97 mmol) and Pd(PPh3)4 (30 mg, 0.026 mmol) were dissolved in a degassed 5:1 tetrahydrofuran: water mixture (4 mL). (4-Hydroxyphenyl)boric acid (140 mg, 1.02 mmol) was then added, and the reaction was heated to reflux under N2 for 24 hours. The product was extracted with dichloromethane (30 mL), washed with water (3×30) and evaporated to dryness. The crude product was purified by column chromatography (silica DCM: hexane) to give impure compound 30 as a brown solid.

[0374] The name of compound 30 is 4-(2,3,6,11,12-penta(pentyloxy)-8-phenyltriphenylene[1,2-d]oxazol-1-yl)phenol.

[0375] Compound 30 has the following characterization data: TOF LD + m / z:869.49([M+1] + 70%),868.52([M] + 70%).

[0376] Example 31 - Synthesis of Compound 31

[0377] Compound 31 was synthesized using the following method. Compound 10 (50.7 mg, 0.071 mmol) was added to a 2-necked round-bottom flask purged with nitrogen for 15 minutes. Dry dichloromethane (20 mL) was then added via a syringe through Suba-Seal (RTM), and the brown stirred solution was cooled to -78 ° C. Boron tribromide (1M in dichloromethane, 391 μL, 0.391 mmol, 5.5 equivalents) was added via a syringe through Suba-Seal (RTM), and the reaction was stirred for 4 hours. The reaction mixture was poured onto crushed ice and stirred until the ice was completely melted, 4 drops of hydrochloric acid (1 M) were added, and the product was extracted with ethyl acetate, washed with water (2×20 mL), dried with MgSO4 and evaporated to dryness. The crude product was used without further purification.

[0378] The name of compound 31 is 8-methyltriphenylene[1,2-d]oxazole-2,3,6,11,12-pentaol.

[0379] Compound 31 has the following characterization data: ES + MS m / z:503.26([M+2(OC5H 11 )] +50%),433.17([M+(OC5H 11 )] + 100%),363.08([M] + 10%).

[0380] Example 32-Synthesis of Compound 32

[0381] Crude compound 31 (26 mg, 0.071 mmol), potassium carbonate (74 mg, 0.533 mmol), potassium iodide (6 mg, 0.036 mmol) were dissolved in dry acetonitrile (35 mL). Then 1 (-2-bromoethoxy)-2-(2-methoxyethoxy)ethane (132 μL, 0.533 mmol) was added via pipette, the reaction was heated to reflux, and stirred in a CaCl2 drying tube for 20 hours. The reaction was cooled to room temperature, the product was extracted with ethyl acetate (20 mL), washed with water (3×20 mL), brine (2×20 mL), and dried over MgSO4 to give crude compound 32 as a brown solid.

[0382] The name of compound 32 is 2,3,6,12-tetrakis(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)-8-methyl-11-(pentyloxy)triphenylene[1,2-d]oxazole.

[0383] Compound 32 has the following characterization data: ES + MS m / z:1017.51([M] + 100%).

[0384] Advantageously, compound 32 is water soluble.

[0385] Example 33 - Synthesis of Compound 33

[0386] Reference now Fig.16 , showing the synthetic route 16 of compound 33.

[0387] The following method was used to synthesize compound 33 from precursor 5. The starting materials for forming precursor 5 were obtained using the method described in J. Mater. Chem. C, 2017, 5, 669-682 (DOI: 10.1039 / C6TC04530H).

[0388] Precursor 5 was synthesized using the following method. 5,6-dimethoxy-2,3,8,9,12,13-hexa(pentyloxy)dibenzo[fg,op]tetracene (681 mg, 0.775 mmol) was dissolved in ether (20 ml), then acetic acid (1.33 ml, 23.24 mmol, 30 equivalents) was added, and the mixture was stirred at room temperature and nitrogen atmosphere for 10 minutes, and then fuming nitric acid (65 μL, 1.55 mmol, 2 equivalents) was added. The reaction mixture was stirred under nitrogen for 20 minutes, and then nitric acid (30 μL, 0.715 mmol, 0.92 equivalents) was added, and the reaction mixture was stirred at room temperature for 20 minutes. The mixture was then quenched with water (10 mL), the organic phase was washed with NaOH (1 M, 2×30 mL), and then vacuum dried to obtain Precursor 5 as a black solid (680 mg, 95%). It was used in the next step without further purification.

[0389] The name of precursor 15 is 5,6-dimethoxy-1-nitro-2,3,8,9,12,13-hexa(pentyloxy)dibenzo[fg,op]tetracene.

[0390] Precursor 5 has the following characterization data: 1 H NMR(400MHz, CDCl3)δ9.16(s,1H),9.01(s,1H),7.95(s,1H),7.84(s,1H),7. 58(s,1H),4.53(t,J=6.7Hz,2H),4.32(t,J=5.1Hz,2H),4.29(t,J=5.3Hz,2H ),4.18–4.14(m,2H),4.14(s,3H),4.13(s,3H),3.95(t,J=6.8Hz,2H),3.95( t,J=7.0Hz,2H),2.11–1.82(m,12H),1.69–1.29(m,24H),1.08–0.84(m,18H). 13 CNMR (101MHz, CDCl3) δ151.9,149.6,149.3,148.7,148.1,147.9,144.4,143.2,14 1.5,124.9,124.8,124.7,124.4,123.1,123.1,122.3,119.4,118.6,116.0,109.5, 109.3,107.6,107.3,104.9,76.3,74.5,74.0,69.5,68.9,68.8,55.8,30.3,30.3, 29.9,29.2,29.0,28.8,28.4,28.3,28.2,28.1,22.6,22.6,22.6,14.1,14.0,14.0. MALDI+ m / z:924.82([M+H] + 30%).

[0391] Precursor 6 was synthesized using the following method. Precursor 5 (680 mg, 0.736 mmol) and NiCl2·6H2O (552 mg, 2.33 mmol, 3 equiv) were dissolved in THF:MeOH (20 mL, 5:4 ratio) to make a yellow solution, and then NaBH4 (586 mg, 15.5 mmol, 20 equiv) was added over 15 minutes. The black reaction mixture was stirred under a nitrogen atmosphere for 40 minutes, after which it was diluted with chloroform and the precipitate was gravity filtered to leave a brown organic phase, which was then dried in vacuo to give Precursor 6 as a brown solid (614 mg, 93%).

[0392] The name of the precursor 6 is 5,6-dimethoxy-2,3,8,9,12,13-hexa(pentyloxy)dibenzo[fg,op]tetracen-1-amine.

[0393] Precursor 6 has the following characterization data: 1 H NMR(300MHz, CDCl3)δ9.09(s,1H),8.98(s,1H),8.67(s,1H),7.97(s,1H),7.90(s,1H) ,4.76(s,2H),4.40(t,J=6.8Hz,2H),4.34(t,J=6.5Hz,2H),4.28(t,J=6.6Hz,2H),4.2 0(t,J=6.6Hz,2H),4.11(s,3H),4.08(s,3H),3.99(t,J=7.0Hz,2H),3.93(t,J=7.0Hz, 2H), 2.07–1.88 (m, 12H), 1.66–1.34 (m, 24H), 1.06–0.88 (m, J = 22.0, 12.0, 7.1Hz, 18H). 13 C NMR (101MHz, CDCl3) δ151.2,148.5,148.2,148.0,146.8,143.8,139.8,136. 9,125.4,125.0,124.5,124.4,123.6,123.5,122.6,120.5,113.9,111.8,11 0.0,109.4,108.6,108.4,104.3,73.9,73.8,69.7,69.2,69.0,55.7,30.4,3 0.3,29.7,29.3,29.1,29.0,28.5,28.4,28.3,22.7,22.6,22.6,14.1,14.0. MALDI +m / z:893.79([M+H] + 100%).

[0394] Precursor 7 was synthesized using the following method. Precursor 6 (147 mg, 0.181 mmol) was dissolved in dry dichloromethane (20 mL) and dry acetonitrile (20 mL). The solution was cooled to 0°C under a nitrogen atmosphere, and then tert-butyl nitrite (34 μL, 0.309 mmol, 1.7 equivalents) and TMSN3 (36 μL, 0.273 mmol, 1.5 equivalents) were added, and the reaction mixture was stirred at 0°C for 10 minutes and then at room temperature for 20 minutes. The solution was then vacuum dried and purified by flash column chromatography (silica, 30% DCM, 70% n-hexane) to give precursor 7 as a white solid (120 mg, 72%).

[0395] The name of precursor 7 is 1-azido-5,6-dimethoxy-2,3,8,9,12,13-hexa(pentyloxy)dibenzo[fg,op]tetracene.

[0396] Precursor 7 has the following characterization data: 1 H NMR(300MHz, CDCl3)δ9.12(s,1H),9.03(s,1H),8.98(s,1H),8.01(s,1H),7.89(s,1H),4.45(t,J=6.7Hz,2H),4.38–4.32(m,2H),4.29(t, J=6.0Hz,2H),4.11(s,3H),4.09(s,3H),4.01(t,2H),3.94(t,J=6.6Hz,2H),2.13–1.84(m,12H),1.69–1.32(m,24H),1.04–0.87(m,18H). 13 C NMR (101MHz, CDCl3) δ151.57,148.85,148.03,147.99,147.89,147.88,146.27,144.06,127.3 0,125.39,124.82,123.99,123.85,123.33,123.17,122.79,120.18,119.39,117.58,112.56,1 09.38,109.10,107.51,104.74,75.30,74.36,73.97,69.64,69.14,69.01,55.81,30.39,30.32,29.53,29.25,29.08,28.94,28.45,28.33,28.23,28.22,22.70,22.62,22.57,14.10,14.01.

[0397] Compound 33 was synthesized using the following method. Under N2 atmosphere, precursor 7 (100 mg; 0.13 mmol) was dissolved in dry toluene (5 mL) and added to a flask containing rhodium octanoate dimer (5 mg; 0.01 mmol). The mixture was heated to reflux and stirred for 20 hours. The reaction was cooled to room temperature and then vacuum dried, and the solid was then purified by flash column chromatography (silicon dioxide, 95% hexane: 5% ethyl acetate) to obtain compound 33 as a white solid (58 mg, 50%).

[0398] The name of compound 33 is 2-butyl-12,13-dimethoxy-5,6,9,10,15-penta(pentyloxy)dibenzo[4,5:9,10]pyrene[1,2-d]oxazole.

[0399] Compound 33 has the following characterization data: 1 H NMR(300MHz, CDCl3)δ10.08(s,1H),9.28(s,1H),9.15(s,1H),8.16(s,1H) ,8.02(s,1H),4.42(t,J=6.0Hz,2H),4.37(d,J=5.8Hz,2H),4.35–4.29(m,J =6.7,3.3Hz,4H),4.12(s,3H),4.11(s,3H),3.98(t,J=6.9Hz,2H),3.18(t, J=7.5Hz,2H),2.09–1.92(m,10H),1.67–1.36(m,24H),1.07–0.90(m,18H). 13 CNMR (101MHz, CDCl3) δ166.1,151.3,149.5,148.8,147.8,147.7,144.0,142.4,138. 4,137.1,125.5,124.9,124.1,124.0,123.7,123.5,123.0,119.9,118.8,116.1,111 .3,109.6,109.4,107.1,104.8,74.5,74.0,69.8,69.0,68.8,55.8,55.7,30.3,30.1 ,29.3,29.1,28.9,28.7,28.5,28.4,28.3,28.2,22.6,22.5,22.3,14.1,14.0,13.8. MALDI + m / z:889.16([M+H] + 100%).

[0400] Example 34 - Synthesis of Compound 34

[0401] Precursor 6 (47 mg; 0.053 mmol), benzoyl chloride (30 μL, 0.265 mmol, 5 equivalents) and diisopropylethylamine (46 μL, 0.265 mmol, 5 equivalents) were dissolved in dry toluene (5 mL) and the mixture was heated to reflux under a nitrogen atmosphere. The reaction mixture was stirred for 1 hour, at which time the mixture was dried in vacuo and the solid was then heated to 240 ° C for 10 minutes. The reaction was cooled to room temperature and the solid was then purified by flash column chromatography (silica, 40% DCM: 60% n-hexane) to give compound 34 as a white solid (16 mg, 33%).

[0402] The name of compound 34 is 12,13-dimethoxy-5,6,9,10,15-penta(pentyloxy)-2-phenyldibenzo[4,5:9,10]pyrene[1,2-d]oxazole.

[0403] Compound 34 has the following characterization data: 1 H NMR(300MHz, CDCl3)δ9.29(s,1H),9.19(s,1H),8.48–8.43(m,2H),8.17(s,1H),8.03(s,1H),7.65–7.59(m,3H),4.53(t,J=6.9Hz,2 H),4.44–4.33(m,6H),4.14(s,3H),4.12(s,3H),3.99(t,J=6.9Hz,2H),2.15–1.90(m,10H),1.71–1.36(m,24H),1.06–0.80(m,18H). 13 C NMR (101MHz, CDCl3) δ166.6,161.8,151.4,149.5,148.9,147.9,147.9,144.1,142.5,138.5,137.7, 132.9,131.5,129.5,129.0,128.4,127.6,127.4,125.6,124.8,124.3,124.0,123.8,123.5,123.3, 119.8,119.7,116.4,111.3,109.7,109.4,106.9,104.8,74.7,74.1,69.8,69.0,64.5,55.8,55.7,3 0.4,30.2,29.7,29.3,29.1,28.9,28.5,28.5,28.4,25.6,22.6,22.5,14.2,14.1,14.1,14.1,14.0. ES + m / z:910.54([M+H] + 100%).

[0404] Example 35 - Synthesis of Compound 35

[0405] Precursor 6 (100 mg; 0.111 mmol), 4-cyanobenzoyl chloride (92 mg, 0.555 mmol, 5 equivalents) and diisopropylethylamine (90 μL, 0.555 mmol, 5 equivalents) were dissolved in dry toluene (5 mL) and the mixture was heated to reflux under a nitrogen atmosphere. The reaction mixture was stirred for 1 hour, at which time the mixture was dried in vacuo and the solid was then heated to 240 ° C for 10 minutes. The reaction was cooled to room temperature and the solid was then purified by flash column chromatography (silica, 40% DCM: 60% n-hexane) to give compound 35 as a white solid (17 mg, 16%).

[0406] The name of compound 35 is 4-(12,13-dimethoxy-5,6,9,10,15-penta(pentyloxy)dibenzo[4,5:9,10]pyrene[1,2-d]oxazol-2-yl)benzonitrile.

[0407] Compound 35 has the following characterization data: 1 H NMR (300MHz, CDCl3) δ10.02(s,1H),9.27(s,1H),9.15(s,1H),8.43(d,J=8 .3Hz,2H),8.13(s,1H),7.99(s,1H),7.84(d,J=8.3Hz,2H),4.45(t,J=6.8 Hz,2H),4.36(dt,J=13.0,6.4Hz,6H),4.14(s,3H),4.12(s,3H),3.97(t,J =6.9Hz,2H),2.12–1.90(m,10H),1.65–1.38(m,24H),1.06–0.88(m,18H). 13 C NMR (100MHz, CDCl3) δ159.8,151.9,149.9,149.5,148.5,148.3,144.6,143.0,138.6,137 .6,133.0,131.5,128.0,125.8,124.8,124.4,123.9,123.8,123.8,121.1,119.9,118.6,1 17.0,114.7,111.5,110.1,109.8,107.1,105.2,75.1,74.4,70.1,69.3,56.2,56.1,30.7 ,30.5,30.0,29.6,29.5,29.3,28.9,28.8,28.7,28.7,23.0,22.9,22.9,14.6,14.5,14.4. MALDI +m / z:934.55([M+H] + 100%).

[0408] Method for synthesizing compound XX

[0409] The following method was used to synthesize compound XX. At 0°C, under a nitrogen atmosphere, Figure 4 Compound 404 (wherein R'=C5H 11 ) (550 mg, 0.632 mmol) was dissolved in dry dichloromethane. A 0.01 M solution (4×64 mL) of Br2 in dichloromethane (256 mL, 2.528 mmol) was then added over 1 hour and monitored by TLC. The reaction was stirred overnight and then quenched by the addition of saturated sodium metabisulfite solution (100 mL). The product was extracted with dichloromethane (30 mL), washed with water (3×30 mL), dried over MgSO4 and evaporated to dryness. The crude product was then purified by column chromatography (silica 40% dichloromethane:hexane) to give compound XX as a yellow solid (220 mg, 36%).

[0410] The name of compound XX is 1-bromo-8-nitro-2,3,6,7,10,11-hexa(pentyloxy)triphenylene.

[0411] Compound XX has the following characterization data: 1HNMR (300 MHz, CDCl3) δ Η :8.78(1H,s),7.79(1H,s),7.69(1H,s),7.42(1H,s),4.25–4.17(8H,m),4.12 –4.06(4H,m),1.97–1.77(12H,m),1.57–1.40(24H,m),1.00–0.93(18H,m)ppm. ES + MS m / z:867.43([M] + 25%).

[0412] It will be appreciated that the method for brominating compound XX can be applied to the phenol oxazoles of the invention, for example, to add additional functionality to the molecule.

[0413] Properties of Triphenylene Derivatives Series 100

[0414] The triphenylene derivative series 100 of the present invention exhibits a number of advantageous properties that can be used in a number of applications. Some of these advantageous properties are presented below in a non-limiting manner.

[0415] Reference Figure 8, shows normalized absorption and emission spectra 800 of Compounds 1 to 6 of Examples 1 to 6 and Compound 403. The solvent used to record the spectra was acetonitrile.

[0416] The absorption spectra (indicated by prefix A) (A1, A2, A3, A4, A5, A6) and emission spectra (indicated by prefix E) (E1, E2, E3, E4, E5, E6) of compounds 1-6 are shown. Due to equipment limitations, the complete emission spectrum E6 of compound 6 could not be detected.

[0417] Also recorded Figure 4 The absorption spectrum A403 and emission spectrum E403 of the intermediate compound 403 (2,3,6,7,10,11-hexa(pentyloxy)triphenylene) are shown and used as a reference.

[0418] Also referring to Table 1, the luminescence data of compounds 1 to 6 are shown. The maximum absorption value λmax (nm), the maximum emission value λmax (nm), the pseudo-Stokes frequency shift pSS (cm -1 ), quantum yield Φ and brightness (M -1 cm -1 ). The luminescence data shown in Table 1 were recorded for each of compounds 1 to 6 in ethyl acetate, 1-octanol and acetonitrile, respectively.

[0419]

[0420]

[0421] Unable to get any value Due to poor solubility, no values ​​could be obtained, so no ∈ data.

[0422] Table 1 Luminescence data of compounds 1 to 6

[0423] Referring also to Table 2, further luminescence data for compounds 1 to 6 are shown. The molar extinction coefficients (E×10 3 )(M -1 cm -1 ) and the maximum absorption value λmax(nm), with 1×10 -7 mol dm -3 The concentrations were recorded in ethyl acetate, 1-octanol and acetonitrile, respectively.

[0424]

[0425]

[0426] Due to the poor solubility of compound 5 in acetonitrile, no values ​​could be obtained. Table 2 Luminescence absorption data of compounds 1 to 6

[0427] The triphenylene derivative series 100, as an example of compounds 1-6, shows many favorable luminescent properties (such as the data in Tables 1 and 2 and Figure 8 These properties are discussed below.

[0428] Large Stokes shift

[0429] Compounds 1-6 show large Stokes shifts compared to many commercially available dyes such as the Alexa Fluor series (J Histochem Cytochem Vol. 51((12)): 1699-1712, 2003). The Stokes shifts of Compounds 1 to 6 (particularly Compound 6) are believed to be some of the largest Stokes shifts observed for known light-emitting organic compounds.

[0430] Additionally, the favorable emission properties such as the Stokes shift can be altered or “tuned” by changing the R group in the series 100 of triphenylene derivatives.

[0431] For example, as shown in Table 1 and Figure 8 As shown, the maximum absorption wavelength of each of compounds 1 to 6 remains relatively constant. However, when the R group changes, that is, the R group changes from an alkyl group (compound 1, where R = C4H9) to a phenyl group (compound 2, where R = Ph) or a polycyclic aromatic hydrocarbon (compounds 3 to 6, where R = naphthalene or anthracene), the maximum emission wavelength undergoes a red shift. This "tunable" property is not observed in many other commercially available dyes.

[0432] It should be noted that by Stokes shift we also refer to the "pseudo" Stokes shift. The IUPAC definition of the Stokes shift requires that the difference in the band maxima of absorption and luminescence arise from the same electronic transition. However, in the literature it is widely referred to in general terms as the difference in excitation and emission wavelengths, regardless of the electronic transition.

[0433] Without wishing to be bound by theory, we believe that the triphenylene derivative series 100 of the present invention is a push-pull twisted internal charge transfer system, wherein the triphenylene moiety, when replaced by five electron donating alkoxy groups (in Figure 1 Displayed as C5H 11) is substituted with a "push" structure. When conjugated coupling is made to the triphenylene structure by an oxazole unit, the R group provides a "pull" structure. Therefore, further stabilization of the excited state can be achieved by increasing the electron-withdrawing properties of the R group. When the energy of the excited state is reduced, this increases the Stokes shift. Advantageously, the triphenylene derivative series 100 of the present invention can be adjusted to provide this characteristic according to the needs of application.

[0434] Emission across the visible spectrum, which varies with the structure of the R group

[0435] Advantageously, the emission spectrum of compound 1-6 spans a large part of the visible spectrum. The R group need not be limited to those disclosed, and can be any alkyl or aryl group. Especially, it has been shown that the R group causes the shift of the emission spectrum along with the change of, for example, different aromatic hydrocarbon groups. The emission shift in the triphenylene derivative series 100 can be predicted with a good certainty level of the R group change, and the visible color of the specific triphenylene derivative obtained by thus predicting. Advantageously, this provides a large amount of analogs, for example, wherein R is an aryl group, so that the emission is the color in the visible spectrum, and the visible color can be "adjusted" by the slight structural change of the R group of the triphenylene derivative series 100 of the present invention.

[0436] High brightness

[0437] Compounds 1 to 6 showed over 100,000 M -1 cm -1 This is comparable to commercially available dyes such as the Alexa Fluor series, for example Alexa Fluor 635 has a molar extinction coefficient of 140,000 M. -1 cm -1 The molar extinction coefficient.

[0438] Compounds 1 to 6 also advantageously exhibit high quantum yields Φ and high brightness values. In this case, the quantum yield Φ is defined as the ratio of the number of photons emitted to the number of photons absorbed.

[0439] Therefore, compounds 1 to 6 showed high values ​​of brightness, which is defined as the product of the molar extinction coefficient and the fluorescence quantum yield.

[0440] Furthermore, it has been surprisingly found that compound 22 has a quantum yield of 93%.

[0441] Solid State Light Emission

[0442] Reference now Fig. 9, which shows a graph of normalized light emission 900 of compounds 1 to 6 in the solid state. The light emission (denoted by the prefix ES) of compounds 1 to 6 in the solid state is shown (ES1, ES2, ES3, ES4, ES5, ES6).

[0443] See also Table 3, showing a comparison of the light emission of compounds 2 to 6 in the solid state and in ethyl acetate, and the difference Δ between these values.

[0444]

[0445]

[0446] Table 3 Light emission data of compounds 2 to 6

[0447] Advantageously, the light emission was substantially unchanged when compounds 2 to 6 were dissolved in ethyl acetate compared to the solid state. This demonstrates the predictability and stability of the light emission behavior.

[0448] Liquid crystal behavior

[0449] Referring to Table 4, DSC (Differential Scanning Calorimetry) thermal analyses of Compounds 1 to 6 are shown.

[0450]

[0451] Phase transition of compound 6 shown in bold below the temperature

[0452] Table 4 DSC properties of compounds 1 to 6

[0453] The phase transitions for each of compounds 1 to 6 are shown, where Cr represents crystallization, X represents an unknown endothermic process, and CoI h Represents a hexagonal columnar phase, CoI x This indicates that compounds 1 to 6 are mesogenic, that is, have liquid crystal properties.

[0454] Also refer to Fig.10 , which shows DSC (Differential Scanning Calorimetry) thermal analysis curves 1000 of phase types of compounds 1 to 6, showing heating and cooling. A crystalline phase, an unknown solid phase, a hexagonal columnar phase, and an unknown liquid crystal phase are shown.

[0455] Photoconductivity

[0456] Referring to Table 5, the values ​​of the average conductivity and average photoconductivity of compounds 1 to 6 at room temperature when irradiated at 350 nm are shown. The molar absorption rate constant (E 350nm ). Also recorded Figure 4The electrical conductivity and photoconductivity of compound 403 shown in FIG. 4 are used as a reference.

[0457]

[0458] Table 5 Electrical conductivity and photoconductivity of compounds 1 to 6

[0459] Advantageously, compounds 1 to 6 show an increase in conductivity, i.e., photoconductivity values, upon light irradiation. The conductivity and photoconductivity of the triphenylene derivatives containing the oxazole moiety are much higher when compared to the reference compound 403, which does not contain the oxazole moiety. More advantageously, when the R group is a polycyclic aromatic hydrocarbon, i.e., for compound 2, where R = Ph, and for compounds 3 and 4, where R = naphthalene, the photoconductivity increases significantly.

[0460] Also refer to Fig.11 , showing the difference between compound 3 and reference compound 403 (shown in Figure 4 ) compared with the photoconductivity experiment 1100. The absorption spectrum 1101 and emission spectrum 1102 of compound 3 were measured in the presence of different ratios of phenyl-C61-butyric acid methyl ester (PCBM). Figure 1103 shows the measurement of the conductivity of reference compound 403 at different temperatures under light irradiation at 350nm. Figure 1104 shows the measurement of the conductivity of compound 3 at different temperatures under light irradiation at 350nm.

[0461] Surprisingly, when the oxazole moiety is introduced, compound 3 shows improved conductivity and photoconductivity, which is characteristic of the triphenylene derivative series 100 of the present invention, compared to the conductivity and photoconductivity of reference compound 403 which does not contain the oxazole moiety substituted with an R group.

[0462] It has also been shown that the compounds within the triphenylene derivative series 100 of the present invention do not undergo any significant photobleaching. The above properties make the triphenylene derivatives of the present invention very suitable for use in solar cells.

[0463] Reference now Fig.12 , showing a photoconductivity experiment 1200 of compound 22. Graphs 1201 , 1202 , and 1203 are shown.

[0464] Graph 1201 shows conductivity measurements at different temperatures for compound 22. The conductivity measurements for compound 22 were recorded with and without irradiation with 350 nm UV light, and the conductivity measurements for compound 22 were recorded with and without irradiation with 350 nm UV light after treatment with HCl.

[0465] Graph 1202 shows conductivity measurements at different pH for compound 22. The conductivity of compound 22 was measured: (i) untreated; (ii) after the first treatment with HCl; (iii) after 20 hours; (iv) after the second treatment with HCl; and (v) after treatment with NaOH.

[0466] Graph 1203 shows conductivity measurements at different pH for compound 22. The conductivity of compound 22 was measured: (i) untreated; (ii) after the first treatment with NaOH; (iii) after 20 hours; (iv) after treatment with HCl; and (v) after the second treatment with NaOH.

[0467] Reference now Fig.13 , showing a photoconductivity experiment 1300 for compound 22. The conductivity of compound 22 was measured: (i) untreated; (ii) untreated in the presence of 350 nm UV light; (iii) after treatment with NaOH (2 M, 15 minutes); (iv) after treatment with NaOH (2 M, 15 minutes) in the presence of 350 nm UV light.

[0468] Reference now Fig.14 , shows a photoconductivity experiment 1400 for compound 3. The conductivity was measured at different temperatures.

[0469] Application of 100 series of triphenylene derivatives in electroluminescent devices

[0470] The triphenylene derivatives of the present invention can also be used in the functional layers of OLEDs (organic light emitting diodes). It has been shown that the triphenylene derivatives of the present invention can exhibit excellent emission, charge transport and / or charge blocking capabilities.

[0471] Reference now Fig.15 , which shows an OLED 1500. The OLED 1500 comprises the following successive layers: substrate 1501, anode 1502, optional hole transport layer 1503, optional electron blocking layer 1504, emissive layer 1505, optional hole blocking layer 1506, optional electron transport layer 1507 and cathode 1508.

[0472] Each of the above layers may include any suitable material known to those skilled in the art, and may include more than one type of material or layer. For example, substrate 1501 may include glass, quartz, polymers, etc. The thickness is not critical, for example, depending on the application of the device, it may be between 25 and 1000 microns. Anode 1502 may include any conductive material such as a metal, or a conductive metal oxide such as ITO (indium tin oxide). Hole transport layer 1503 may include, for example, 1,4-bis[(1-naphthylphenyl)-amino]biphenyl (NPD). Emission layer 1505 may include tris(8-hydroxyquinoline)aluminum. Hole blocking layer 1506 may include 2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline (bath cuproline, BCP). Electron transport layer 1507 may include, for example, a metal chelate, such as tris(8-hydroxyquinoline)aluminum. Cathode 1508 may include any metal, such as aluminum, lithium, magnesium and / or calcium.

[0473] Emissive layer 1505 includes a triphenylene derivative of the present invention, such as triphenylene derivative series 100 .

[0474] The OLED 1500 was manufactured as follows:

[0475] • Patterning an anode 1502 on a clean substrate 1501 .

[0476] The substrate 1501 patterned with the anode 1502 is treated with oxygen for 1 to 5 minutes.

[0477] The substrate 1501 patterned with the anode 1502 is placed in a thermal evaporator and the pressure is reduced to less than 6×10 -6 Entrust.

[0478] The hole transport layer 1503, the electron blocking layer 1504, the emission layer 1505, the hole blocking layer 1506, the electron transport layer 1507 and the cathode 1508 were successively formed in the order listed by thermal evaporation.

[0479] Those skilled in the art will recognize that several variations on the foregoing embodiments are contemplated without departing from the scope of the present invention. For example, the R groups of the triphenylene derivative series 100 and precursors 1 and 2 need not be limited to C5H 11 and may be any stable alkyl or aryl group capable of alkylating the phenol portion of the triphenylene moiety.

[0480] Advantageously, the series of triphenylene derivatives 100 of the present invention can be further functionalized, for example by derivatizing functional groups within the R group. This provides the possibility of using the triphenylene derivatives of the present invention as biomarkers or probes, for example.

[0481] Those skilled in the art will also recognize that any number of combinations of the foregoing features and / or features shown in the accompanying drawings provide significant advantages over the prior art and are therefore within the scope of the invention described herein.

Claims

1. A polycyclic aromatic hydrocarbon derivative represented by the following general formula: Wherein R independently represents an aromatic group or is selected from: methyl, ethyl, propyl or butyl, An alkyl chain containing an unsaturated portion, Alkyl chains containing heteroatoms, An alkyl chain containing an aromatic moiety, Alkyl chains containing functional groups for further derivatization with polycyclic aromatic hydrocarbons, or crown ether; p is an integer from 1 to 2; q and s are independently integers from 1 to 4; Y 1 , Y 2 and Y 3 independently represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, OH, a carboxylic acid group, a diol, an alkoxy group, a thioalkoxy group, an amino group, an acetate, an amide, a thioamide, a thioester, an azo group, a silyl group, an alkylated nitrogen atom, a cyano group, a nitro group, an alkyl group, a functionalized alkyl group, and / or an aryl group, or a functionalized aryl group.

2. The polycyclic aromatic hydrocarbon derivative according to claim 1, wherein the heteroatom is selected from fluorine, chlorine, bromine, iodine, oxygen, sulfur, and nitrogen.

3. The polycyclic aromatic hydrocarbon derivative according to claim 1, wherein the functional group is selected from one or more of azide, carbonyl, alcohol, halogen or olefin. The polycyclic aromatic hydrocarbon derivative according to claim 1 , wherein the functionalized aromatic group is selected from a phenolic group.

5. The polycyclic aromatic hydrocarbon derivative according to claim 1, which is represented by the following general formula: Wherein R independently represents an aromatic group or is selected from: methyl, ethyl, propyl or butyl, An alkyl chain containing an unsaturated portion, Alkyl chains containing heteroatoms, An alkyl chain containing an aromatic moiety, Alkyl chains containing functional groups for further derivatization with polycyclic aromatic hydrocarbons, or crown ether; A independently represents a hydrogen atom, an alkyl group containing 1 to 20 carbons, or an alkyl ether; J independently represents a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, an alkylated oxygen atom, an alkylated nitrogen atom, a cyano group, a nitro group, an alkyl group, a functionalized alkyl group, and / or an aryl group, or a functionalized aryl group. The polycyclic aromatic hydrocarbon derivative according to claim 5 , wherein the heteroatom is selected from fluorine, chlorine, bromine, iodine, oxygen, sulfur, and nitrogen.

7. The polycyclic aromatic hydrocarbon derivative according to claim 5, wherein the functional group is selected from one or more of azide, carbonyl, alcohol, halogen or olefin.

8. The polycyclic aromatic hydrocarbon derivative according to any one of claims 1 to 7, wherein R is an alkyl group, an aromatic group, a heterocyclic aromatic group or a polycyclic aromatic hydrocarbon.

9. The polycyclic aromatic hydrocarbon derivative according to any one of claims 1 to 7, which is selected from the structures shown below:

10. A device comprising the polycyclic aromatic hydrocarbon derivative according to any one of claims 1 to 7.

11. The device according to claim 10, wherein the device is an organic electroluminescent device, an OPV (organic photovoltaic) device, a thin film transistor or a liquid crystal display.

12. A method for synthesizing a polycyclic aromatic hydrocarbon derivative P3, the method comprising the following reaction formula: wherein SM3 represents a polycyclic aromatic hydrocarbon core, and P3 represents a polycyclic aromatic hydrocarbon derivative; p is an integer from 1 to 2; q and s are integers from 1 to 4; Y 1 , Y 2 and Y 3 independently represent a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, OH, a carboxylic acid group, a diol, an alkoxy group, a thioalkoxy group, an amino group, an acetate, an amide, a thioamide, a thioester, an azo group, a silyl group, an alkylated nitrogen atom, a cyano group, a nitro group, an alkyl group or a functionalized alkyl group, and / or an aryl group or a functionalized aryl group; G is an alkyl group; N is a nitrogen atom; B is two hydrogen atoms; E represents a reagent; R independently represents an aromatic group or is selected from: methyl, ethyl, propyl, butyl or nonyl, An alkyl chain containing an unsaturated portion, Alkyl chains containing heteroatoms, An alkyl chain containing an aromatic moiety, Alkyl chains containing functional groups for further derivatization with polycyclic aromatic hydrocarbons, or crown ether; Z is a hydroxyl group, a chlorine atom, a bromine atom, or any good leaving group; And wherein the polycyclic aromatic hydrocarbon core SM3 and the reagent E undergo an intermolecular coupling reaction to produce the polycyclic aromatic hydrocarbon derivative P3.

13. The method according to claim 12, wherein the heteroatom is selected from fluorine, chlorine, bromine, iodine, oxygen, sulfur, nitrogen.

14. The method of claim 12, wherein the functional group is selected from one or more of azide, carbonyl, alcohol, halogen or olefin.

15. A method for synthesizing a triphenylene derivative P4, comprising the following reaction formula: Where SM4 represents a triphenylene core, and P4 represents a triphenylene derivative; A independently represents a hydrogen atom, an aryl group, an alkyl group containing 1 to 20 carbons; J independently represents a hydrogen atom, a deuterium atom, a fluorine atom, a chlorine atom, a bromine atom, an alkylated oxygen atom, an alkylated nitrogen atom, a cyano group, a nitro group, an alkyl group or a functionalized alkyl group, and / or an aryl group or a functionalized aryl group, G is an alkyl group; E represents a reagent; R independently represents an aromatic group or is selected from: methyl, ethyl, propyl, butyl or nonyl, An alkyl chain containing an unsaturated portion, Alkyl chains containing heteroatoms, An alkyl chain containing an aromatic moiety, Alkyl chains containing functional groups for further derivatization with polycyclic aromatic hydrocarbons, or crown ether; Z is a hydroxyl group, a chlorine atom, a bromine atom, or any good leaving group; And wherein the triphenylene core SM4 and the reagent E undergo an intermolecular coupling reaction to produce a triphenylene derivative P4.

16. The method of claim 15, wherein the heteroatom is selected from fluorine, chlorine, bromine, iodine, oxygen, sulfur, nitrogen.

17. The method of claim 15, wherein the functional group is selected from one or more of azide, carbonyl, alcohol, halogen or olefin.

18. The method for synthesizing a triphenylene derivative 100 according to claim 15, comprising the following reaction formula: Wherein R independently represents an aromatic group or is selected from: methyl, ethyl, propyl, butyl or nonyl, An alkyl chain containing an unsaturated portion, Alkyl chains containing heteroatoms, An alkyl chain containing an aromatic moiety, Alkyl chains containing functional groups for further derivatization with polycyclic aromatic hydrocarbons, or crown ether.

19. The method of claim 18, wherein the heteroatom is selected from fluorine, chlorine, bromine, iodine, oxygen, sulfur, nitrogen.

20. The method of claim 18, wherein the functional group is selected from one or more of azide, carbonyl, alcohol, halogen, or olefin.

21. The method of any one of claims 12-20, further comprising a catalyst.

22. The process of claim 21, wherein the catalyst is a palladium (Pd(II)) catalyst.

23. The process of claim 21, wherein the catalyst is palladium acetate (Pd(OAc)2.

24. The method according to any one of claims 12-20, wherein the reagent E is a carboxylic acid.

25. The method of any one of claims 12-20, wherein the method further comprises adding another reagent to replace the Z group of reagent E with a good leaving group.

26. The method according to any one of claims 12-20, wherein the reagent E is an acyl chloride.

27. A biomarker or biotag comprising the polycyclic aromatic hydrocarbon derivative according to any one of claims 1 to 7.